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The!mitochondria! are! a! vibrant! hub! for!many! problems! that! occur! in! Alzheimer’s!disease.!The!enzyme!amyloidSβ!binding!alcohol!dehydrogenase!(ABAD)!and!Cyclophilin!D! (CypD)! are! two! key! mitochondrial! proteins! that! have! essential! functions! in!Alzheimer’s!disease.!ABAD!is!crucial! in!the!generation!of!energy!via!the!βSoxidation!of!fatty! acids,! and!CypD!has!been! linked! to!Alzheimer’s!disease! through! the! initiation!of!necrosis.!!Changes! in! glucose! metabolism! have! been! observed! in! the! brains! of! Alzheimer’s!disease!sufferers.!This!suggests!that!neurons!require!an!alternative!energy!source!that!can!bypass!glycolysis!in!order!to!produce!energy.!The!oxidation!of!fatty!acids!is!crucial!at! this! point! as! the! products! of! this! catabolism! can! feed! into! the! second! stage! of! the!respiratory! cycle.! In! Alzheimer’s! disease,! AmyloidSβ! (Aβ)! has! been! found! to! bind! to!ABAD!distorting!the!catalytic!site!changing!its!activity.!!The! first! objective! of! this! thesis!was! to! investigate! a! potential! previously! reported!interaction! between! ABAD! and! CypD.! To! explore! this! further,! FRET! analysis! and!immunoprecipitation! studies! were! conducted.! Though! no! strong! interactions! were!observed! from! the! immunoprecipitation! studies,! live! cell! FRET! analysis! did! reveal! a!small/weak! interaction! between! CypD! and! ABAD.! Additional! studies! also! showed! a!decrease! in! ABAD! activity! in! the! presence! of! CypD,! suggesting! that! there! could! be!functional!consequences!from!this!interaction!between!CypD!and!ABAD.!I!also!explored!the!effect!of!changing!cellular!energy!sources!on!the!activity!of!ABAD.!!ABAD!activity!was!found!to!increase!under!conditions!of!reduced!glucose!in!both!HEK!293!and!SKSNSSH!cells!expressing!ABAD.!In!addition,!Alois!Alzheimer!initially!reported!changes! in! lipids.! These! reported! changes! in! lipids! were! explored! under! conditions!where!there!was!increased!expression!of!ABAD!and!in!the!presence!of!Aβ.!On!the!whole,!the! changes! suggested! that! there! was! a! shift! in! the! metabolism! of! fatty! acids! when!ABAD!was! expressed! further! implying! a! change! in! energy! sources! in! the! Alzheimer’s!disease!brain.!!!!!
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1.1 ALZHEIMER’S!DISEASE!!Alzheimer’s! disease! (AD)! is! a! debilitating! progressive! disorder,! initially!characterised! clinically! by! abnormalities! in! memory,! language,! judgement! and!orientation,!which!all!stem!from!a!gradual!deficit!in!declarative!memory!(Muirhead!et! al.,! 2010a,! Alzheimer's! Research! Trust,! 2010).! Dementia! symptoms! such! as!memory! loss! appear!many! years! after! the! onset! of! the!disease,! as! the!decline! in!memory!is!attributed!to!the!loss!of!neuronal!cells.!!Neuronal!loss!occurs!in!specific!regions! of! the! brain,! starting! with! degeneration! of! the! entorhinal! cortex,!hippocampus!and!the!cerebral!cortex.! !The!progressive!loss!of!neurons!in!the!AD!brain!leads!to!a!notably!large!reduction!in!brain!mass!post!mortem.!AD! is! present! in! two! forms,! Familial! Alzheimer’s! Disease! (FAD)! and! Sporadic!Alzheimer’s! Disease.! FAD! is! most! commonly! known! as! early! onset! AD,! as!symptoms! of! dementia! start! around! 40! years! of! age.! FAD! is! passed! through!generations! via! mutations! in! genes! involved! in! specific! chemical! pathways!associated!with!the!biochemical!hallmarks!of!the!disease.!!In!comparison,!sporadic!AD! occurs! past! the! age! of! 65! and! has! less! strongly! associated! links! to! genetic!mutations;!but!an! increased!prevalence!of!the!Apolipoprotein!ε4!(ApoE!ε4)!allele!has!been!shown!to!increase!the!likelihood!of!developing!AD!(Rebeck!et!al.,!1993).!Due! to! the! population! of! individuals! studied! and! the! selection! of! control!participants,!the!risk!of!developing!AD!and!having!ε4!homozygotes!varies!between!studies.! Reported! findings! have! suggested! that! heterozygote! carriers! of! ApoE! ε4!have!a!20S70%! increased!risk!of!developing!AD!(Tsai!et!al.,!1994,!ErtekinSTaner,!2007)! Recent! genomeSwide! association! studies! (GWAS)! have! reported! two! new!genes!linked!to!AD:!Clusterin!gene!(CLU,!also!known!as!Apolipoprotein!J)!found!on!chromosome! 8! and! involved! in! pathways! that! lead! to! inflammation! within! the!brain;! PhosphatidylinositolSbinding! clatharin! assembly! lymphoidSmyeloid!
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(PICALM)! gene,! which! is! implicated! in! the! trafficking! mechanisms! in! cells,!particularly!the!release!of!synaptic!vesicles!from!the!preSsynaptic!terminal!(Harold!et!al.,!2009,!Kamboh!et!al.,!in)press,)Borovecki!et!al.,!2011)!Early! stage! diagnosis! of! sporadic! AD! is! very! difficult! as! ‘forgetfulness’! is! a!common!occurrence!in!aging.!!However,!one!of!the!main!tests!conducted!to!define!dementia!is!the!Mini!Mental!State!Examination!(MMSE)!which!tests!memory!based!on! a! scoring! system! (Dajani,! 2011).! Further! diagnostic! procedures! include!neuroimaging! using! MRI! (magnetic! resonance! imaging),! measuring! glucose!metabolism!using!(18F)!Fluorodeoxyglucose!positron!emission!tomography!(FDGSPET)!and!the!presence!of!specific!biomarkers!such!as!amyloidSβ42!(Aβ42),!!total!tau!and! hyperphosphorylated! tau! in! the! cerebrospinal! fluid! (CSF)! of! AD! patients!(Blennow,!2006,!Blennow!et!al.,!2010,!Jack!et!al.,!2008).!Since! the! first! recorded! case! of! AD! in! 1906,! it! has! now! become! the! most!prevalent!form!of!neurodegeneration!in!the!UK!and!as!the!greatest!risk!factor!for!AD!is!age,!the!growing!population!of!elderly!people!indicates!a!quickly!developing!social! and! economic! problem! (Alzheimer's! Research!Trust,! 2010).! In! addition! to!the!risk!of!aging!as!a!precursor!to!AD,!poor!diet!and!lack!of!exercise!are!all!seen!to!exacerbate!the!risk!of!developing!AD!(Judd,!2011).!!
1.2!NEUROPATHOLOGY!OF!ALZHEIMER’S!DISEASE!!!Three! pathologies! seen! in! AD! brains! distinguish! AD! from! other! forms! of!dementia! and! are! thought! to! be! the! key! contributing! factors! of! the! disease.!Neurofibrillary! tau! ‘tangles’,! AmyloidS! β! ‘plaques’! and! lipoid! granules! were! first!identified!by!Alois!Alzheimer!upon!postSmortem!of!Auguste!Deter,!later!diagnosed!as! the! first! reported! case! of! AD! (Foley,! 2010).! The! two! former,! distinct!histopathological! features! have! been! widely! investigated! since! their! initial!discovery,!and!the!presence!of!both!allow!for!a!definitive!diagnosis!of!AD!at!postSmortem.!!!
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1.2.1!LIPID!GRANULES!The! occurrence! of! lipid! granules! in! the! AD! brain! signifies! an! accumulation! of!insoluble! materials.! Lipid! deposits! are! commonly! seen! in! aged! brains! but! are!excessively!present!in!AD!(Foley,!2010).!Liposomic!phagocytosis!of!highly!oxidised!cellular!components!form!these!lipid!granules!(Foley,!2010,!D'Andrea!et!al.,!2002).!!Analysis! of! the! lipid! components! in! AD! brains! highlights! two! key! lipid! classes,!ceramide!and!sphingomyelin!(see!section!1.4.2)!at!abnormal!levels,!and!the!change!in!these!lipids!has!been!hypothesised!to!have!effects!on!neuronal!functioning!(Han!et!al.,!2011).!!Although! it! has! not! been! widely! studied,! the! role! for! lipids! in! AD! is! mainly!through!membrane!composition.!In!AD!brains,!the!lipid!content!of!membranes!is!of!particular! importance! in! the! generation! of! Amyloid! β! (Aβ)! and! consequently!changing! the! lipid! composition! and! their! relative! levels! modifies! Aβ! production!(see!section!1.4.2).!Additionally,!particular!lipids!have!been!seen!to!have!protective!roles! in! attenuating! Aβ! accumulation,! again! through! changes! in! the! lipid!membrane!composition!(FlorentSBechard!et!al.,!2009).!!!!
1.2.2!NEUROFIBRILLARY!TANGLES!Neurofibrillary! tangles! (NFT)!are!made! from!a!microtubuleSassociated!protein!called!tau!which!becomes!hyperphosphorylated!and!subsequently!aggregates!into!!paired!helical!cores!that!are!the!precursors!of!larger!aggregates!known!as!tangles!(Goedert! et! al.,! 1988).! !The! tau!protein! is!part!of! the!neuronal! cytoskeleton,! and!hyperphosphorylated! tau! is! particularly! located! in! the! frontal! cortex! and! the!hippocampus,!which!are!expressly!affected! in!AD!(Goedert!et!al.,!1988,!Pooler!et!al.,!2011).!Tau!binds!to!and!stabilises!microtubules!in!neuronal!processes!i.e.!when!abnormal! phosphorylation! of! tau! occurs,! synaptic! and! neuronal! functioning! are!compromised!as!axonal!transport!is!affected!due!to!its!involvement!on!the!function!of!microtubules!(Stoothoff!and!Johnson,!2005,!Avila,!2006).!!Specifically!excessive!phosphorylation!prevents!tau!from!binding!to!microtubules!and!it!is!hypothesised!that!the!aggregation!of!tau,!seen!in!AD,!causes!transportation!along!neuronal!axons!
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to!be!reversed,!consequently!increasing!movement!of!cell!components!into!the!cell!body!(Mandelkow!et!al.,!2003).!This!is!supported!by!the!finding!that!neuronal!axon!processes! in! the! hippocampus! of! AD! transgenic! mouse! models! have! reduced!number!of!mitochondria!implying!a!shift!in!their!localization!(Pigino!et!al.,!2003).!)Tau! localization! is! crucial! to! its! function.! It! has! recently! been! shown! that! deSphosphorylation!of!tau!causes!it!to!be!trafficked!to!the!neuronal!membrane,!away!from!the!cytosol!suggesting!a!stabilizing!role!for!tau!at!the!cell!membrane!(Pooler!et!al.,!2011).!This!finding!is!important!as!it!suggests!that!hyperphosphorylation!of!tau,!in!AD,!could!potentially!alter!any!effects!tau!exerts!on!the!neuronal!membrane.!!Research!supporting!this!has!found!that!the!accumulation!of!hyperphosphorylated!tau! occurs! within! the! cytosol! and! not! at! the! neuronal! membrane! (Iqbal! et! al.,!2005).!
1.2.3!βSAMYLOID!PLAQUES!Highly! fibrillated! neuritic! plaques,! found! initially! in! the! extracellular!environment! of! postSmortem! AD! brains,! are! made! from! an! aggregated! peptide!called!Aβ.! !Aβ!is!present! in!multiple!forms!in!AD,! including!monomers,!oligomers!and!fibrils!and!in!differing!amino!acid!lengths!(e.g.!Aβ40!and!Aβ42).!!!Indeed,!Ahmed!et! al.! (2010)! showed! that! Aβ! is! much! more! toxic! in! its! oligomeric! state! in!comparison!to!the!more!stable!Aβ!fibrils,!which!implies!that!the!smaller!forms!of!Aβ!are!able!to!affect!more!cellular!activities!than!the!larger!aggregates!.!Zhang!et!al.)(2002)! also! investigated! the! toxicity! of! the! multimeric! forms! of! Aβ! using!microinjection,!inserting!different!forms!of!Aβ!into!the!cytosol!of!neurons.!Analysis!of!the!results!showed!that!Aβ42!was!the!most!toxic!form,!both!in!its!nonSfibrillized!(monomers,! dimers,! oligomers! and!polymers)! and! fibrillized! forms! (Zhang! et! al.,!2002).!!!!!
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1.2.3.1!GENERATION!OF!AMYLOIDSβ!PEPTIDE!The! differing! lengths! of! Aβ! are! produced! by! sequential! cleavage! of! a! larger!transmembrane!glycoprotein!called!the!amyloid!precursor!protein!(APP).! !APP! is!known! to! be! localised! within! the! endoplasmic! reticulum! (ER),! Golgi! body,! lipid!rafts! and! cell! membranes! (Zhong! et! al.,! 1994,! Culvenor! et! al.,! 1997).! This!membraneSspanning!protein!can!undergo!two!cleavage!pathways!rendering!either!insoluble!Aβ!peptides!of! either!40!or!42!amino!acids! length!or!a! soluble!peptide!called!P3!(Figure!1.1)(Blennow,!2006,!Haass!et!al.,!1993):!!
NONJAMYLOIDGENIC)PATHWAY:!Once!APP!has!reached!maturation!and!its!CSterminus! is! embedded! in! the! membrane,! the! long! NSterminal! region! is!proteolytically! cleaved! by! αSsecretase,! releasing! a! large! soluble! APP! ectodomain!(Haass! et! al.,! 1993,!Blennow,!2006,! Zhong! et! al.,! 1994).!The! remaining!10kDa!CSterminal! fragment! is! further! cleaved! by! γSsecretase! to! produce! P3.! Primary!cleavage!by!αSsecretase!prevents!the!formation!of!toxic!Aβ,!as!the!cleavage!site!is!present! within! the! Aβ! fraction! of! the! APP! protein! (Mattson,! 2004a).! One!hypothesis!for!Aβ!formation!suggests!that!decreased!αSsecretase!activity!is!at!fault,!as!lower!levels!of!the!soluble!APP!ectodomain!have!been!measured!in!AD!patients!(Lannfelt!et!al.,!1995).!!!!!
AMYLOIDGENIC) PATHWAY:! ! Differences! in!APP!processing!during! the! initial!cleavage,!causes!the!formation!of!the!different!Aβ!isoforms.!!In!the!generation!of!Aβ!the! first! enzyme! to! cleave! APP! is! βSsecretase! which! leaves! a! 99! amino! acid!fragment!in!the!membrane!(Blennow,!2006).!!This!is!then!cleaved!by!γSsecretase!to!form!the!insoluble!Aβ!peptide!either!of!40!or!42!amino!acids,!the!differing!lengths!are!dependent!on!the!original! isoform!of!APP!and!the!intramembranous!cleavage!by!γSsecretase!(Citron!et!al.,!1995,!Wolozin,!2001).!In!sporadic!AD!an!elevation!in!levels! of! the! βSsecretase! active! component,! βSsite! APP! cleavage! enzyme! (BACE),!increases! the! production! and! accumulation! of! Aβ! (Cruts! et! al.,! 2001,! Li! et! al.,!2004a).! ! The!preference!of! the! amyloidgenic!pathway! increases! levels! of!Aβ!and!further!explanations!below!(and!section!1.4.2)!give!evidence!for!this!preference!in!AD.!
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The! production! of! Aβ!was! discovered! to! occur! under! normal! cell! functioning,!suggesting!that!Aβ!peptide!can!be!broken!down!or!used!elsewhere!in!a!nonStoxic!form!(Haass!et!al.,!1992).!A!recent!study!suggests!that!one!method!for!breakdown!of! Aβ! is! by! a! mitochondrial! peptidase! which! specifically! degrades! ‘short!unstructured! peptides’,! such! as! Aβ.! This! peptidase! has! been! named! PreP!peptidasome!(Falkevall!et!al.,!2006).!!Transgenic!mice!overexpressing!mutant!APP!(Tg!mAPP)!show!an!accumulation!of!Aβ,! implying!that!PreP!is!unable!to! function!fully!in!degrading!an!abundance!of!Aβ,!resulting!in!the!buildSup!of!Aβ)observed!in)!AD! (Yao! et! al.,! 2011).! Furthermore! small! quantities! of! Aβ! are! less! likely! to!aggregate!and!could!be!broken!down!by!PreP!peptidasome.!!!There!are!a!number!of!gene!mutations!in!FAD,!which!are!derived!from!missense!mutations! in! the! APP! gene,! causing! APP! processing! problems! and! enhanced! Aβ!production.! Particularly! mutations! of! APP! linked! to! the! activity! of! γSsecretase,!which! is! dependent! on! its! active! component! Presenilin! (Wisniewski! and!Sigurdsson,! 2010).! ! Over! 100! mutations! have! been! found! in! the! encoding! gene!(PSEN)! and! they! are! seen! to! enhance! Aβ! production! (Sastre! et! al.,! 2001,! De!Strooper,!2007).!!!! !!!!!!!!!!Figure! 1S1:! APP! processing! occurs! in! cellular! membranes.! Initial! cleavage! occurs!out!with!the!membrane,!whereas!in!both!the!nonSamyloidgenic!and!the!amyloigenic!pathways!γSsecretase!cleaves!within!the!membrane!(Mattson,!2004b)!
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Aβ)AND)LIPID)MEMBRANES)As!well!as!gene!mutations! that!can! influence!Aβ!production,! lipid!composition!within!the!plasma!membrane!is!also!seen!to!influence!Aβ!generation!in!AD.!Indeed!key! lipids! that! are! reportedly! linked! in! AD! include! cholesterol,! fatty! acids,!sphingomyelin!and!phospholipids.!The! lipid!membrane!bilayer!of!cells! is! thought!to! be! heavily! involved! in! the! trafficking! and! regulation! of! membrane! spanning!proteins.! Significantly! the! cleavage! processes! that! lead! to! the! production! of! Aβ!include! the! transmembrane! protein! APP! which! is! influenced! by! the! balanced!composition!of!lipids!in!the!membrane.!The!lipid!membrane!content!is!crucial!for!the! fluidity! of! the! membrane! which! in! turn! determines! the! activities! of! the!membrane!(Vestergaard!et!al.,!2008).!For!example,!the!presence!of!cholesterol!and!sphingolipids! in! lipid! membranes! decrease! its! fluidity,! due! to! the! rigidity! of!cholesterol!and!the!stabilising!properties!of!sphingolipids!(Wolozin,!2001).!!!Early! studies! into! lipid! membrane! composition! in! AD! brains,! reported! that!!levels! of! phospholipids,! specifically! phosphatidylcholine! (PC),! in! the! membrane!were!inclined!to!be!lower!compared!in!AD!tissue!samples!to!controls!(Nitsch!et!al.,!1992).! The! effect! of! changes! in! the! lipid! content! of! membranes! has! large!consequences! in!AD!as! the!membrane!associated!proteins!seen! in!Aβ!production!such! as! γSsecretase! and! βSsecretase! occupy! cholesterol! rich! lipid!membranes! in!comparison! to! the! nonSamyloidgenic! processing! pathway,! where! αSsecretase!preferentially! occupies! phospholipid!membranes! (Vestergaard! et! al.,! 2008).! This!favouritism!of!lipid!rich!membranes!is!shown!by!the!increased!Aβ!production!from!cholesterol!rich!lipid!rafts.!!!!Ehehalt!et!al.!(2003)!suggested!that!APP!processing!occurs!in!two!main!areas!within! the!cell,! at! the!cell!membrane!and! lipid!rafts.!Lipid!rafts!consist!mainly!of!cholesterol! and! sphingolipids! making! the! membrane! very! rigid! (Wolozin,! 2001,!Vestergaard!et! al.,! 2008).!Using!cholesterol! reducing!drugs,! statins,!Ehehalt! et! al.!(2003)!decreased!cholesterol!levels!in!mouse!neuroblastoma!N2a!cells!and!found!that!APP!generation!of!Aβ!was!prevented!.!!Statins!work!to!inhibit!the!intracellular!production! of! cholesterol! from! the! ER.! Further! investigations! found! that! by!
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increasing! αSsecretase! activity! and! depleting! cholesterol,! Aβ! production! was!greatly!reduced!and!the!activity!of!βS!and!γS!secretase!was!also!reduced!(Kojro!et!al.,!2001).!!Also!observed!was!the!increased!fluidity!of!the!lipid!membrane!when!αSsecretase! activity! was! expressed! (Kojro! et! al.,! 2001).! ! The! use! of! statins! in! AD!appears!to!shift!the!cleavage!of!APP!to!the!nonSamyloidgenic!pathway!reducing!the!generation!of!Aβ!(Kojro!et!al.,!2001).!The!reaction!of!primary!hippocampal!neurons!and!animal!models!to!statins!shows!a!significant!decrease!in!Aβ40!and!Aβ42!levels!(Fassbender!et!al.,!2001).!!!!To!determine!if!the!reduction!in!Aβ!caused!by!decreasing!cholesterol!would!be!a!beneficial!therapeutic!target,!transgenic!mice!were!treated!with!statins!and!their!memory! assessed.! The! results! revealed! that! statins! did! improve! learning! and!memory!impairments;!however,!there!appeared!to!be!no!reduction!in!Aβ!levels!in!comparison! to! controls! (Li! et! al.,! 2006).! This! suggests! that! by! reducing! Aβ!production! by! increasing! membrane! fluidity! does! not! have! any! effect! on! the!degradation! of! Aβ! accumulation! and! by! slowing! the! generation! of! Aβ! memory!improvements!occur.!Indeed!cholesterol!has!been!found!to!have!effects!other!than!altering!membrane! fluidity!and!enhancing!Aβ!production,! as! cholesterol!micelles!were! found!to!bind!to!Aβ!directly!using!transmission!electron!microscopy!(TEM)!and!consequently!induce!fibrillisation!(Harris,!2008).!!!1.2.3.2!INTRACELLULAR!ACCUMULATION!OF!AMYLOIDSβ!PEPTIDE!The! original! theory! for! AD! implied! that! the! problem! stemmed! from! the!extracellular! accumulation! of! Aβ! plaques.! It! was! hypothesised! that! insoluble! Aβ!aggregates! accumulated! within! the! endosomes! and! lysosomes,! unable! to! be!degraded!they!were!then!released!into!the!extracellular!environment!(Golde!et!al.,!1992,! Yang! et! al.,! 1999,! Gouras! et! al.,! 2005).! However,! Wirths! et! al.) (2001)!established! that! Aβ! accumulation! also! occurs! within! hippocampal! neurons! of!doubleStransgenic!mice!(expressing!human!mAPP!and!human!mutant!presenilinS1)!before! any! extracellular! plaque! deposits! develop! (Wirths,! 2001).! Many! other!studies!report!similar! findings!of!Aβ!accumulation!within!neurons,! specifically! in!
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patients!with!FAD!and!preceding!NFT!generation!(Gouras!et!al.,!2000,!Gouras!et!al.,!2005,!RoveletSLecrux!et!al.,!2006).!!!The!presence!of!Aβ!before!any!other!AD!symptoms!or!pathologies!suggests!that!Aβ! is! having! an! effect! intracellularly! that! could! cause! cytotoxicity,! necrosis! or!apoptosis!to!instigate!neuronal!loss.!!From!this!it!can!be!deduced!that!intracellular!Aβ!is!one!of!the!earliest!factors!in!the!development!of!AD.!
Regions)of)Intracellular)Aβ)Accumulation)))Aβ! has! been! found! in! many! different! sites! within! neurons! mainly! areas!associated! with! membranes! such! as! the! ER,! lipid! rafts,! synapse,! multivesicular!bodies!(MVB)!and!the!mitochondrial!membrane!(Buckig!et!al.,!2002,!Takahashi!et!al.,!2002,!Kawarabayashi!et!al.,!2004,!Manczak!et!al.,!2006).!!!Cook! et! al.! (1997)! found! that! APP! coSlocalised! with! the! ER! as! APP! was!discovered! to! have! an! ER! targeting! sequence! and! is! modified! here! before!transportation! to! the! Golgi! apparatus! (Cook! et! al.,! 1997,! Salminen! et! al.,! 2009).!!When!membrane!trafficking!from!the!ER!was!inhibited,!so!that!APP!was!retained!in!the!ER,!Aβ!was!still!seen!to!be!generated!providing!evidence!that!the!ER!is!a!site!for!Aβ!production!and!that!fullSlength!of!APP!is!present!at!this!point!and!is!capable!of!being!cleaved!within!the!ER!(Cook!et!al.,!1997).!!In! addition! to! spanning! the! ER!membrane,! APP! is! also! present! in! cholesterol!rich! lipid! rafts! and! as! such! these! are! increasingly! linked! to! Aβ! production!(Wolozin,!2001).!The! low! fluidity!of! the! lipid! raft!membrane,! caused!by!elevated!levels!of!cholesterol!and!sphingolipids,!are!connected!to!enhanced!Aβ!generation!in! these! lipid! rafts,! whereas! P3! production! is! favoured! in! membranous! regions!containing! low!cholesterol!with! increased!membrane! fluidity!(Kojro!et!al.,!2001).!!In!conjunction!with!this,!BACE!cleavage!activity!has!been!found!to!decrease!upon!reduction!in!the!level!of!cholesterol!within!the!neuronal!cell!line,!SHSSY5Y!implying!that!Aβ!production!is!reduced!when!cholesterol!levels!are!low!(Cordy!et!al.,!2003).!!It! has! been! shown! by! electron! microscopy! that! Aβ! accumulates! on! both! the!outside! and! inside! of!MVB! (Takahashi! et! al.,! 2002).! ! It! is! thought! that! after!APP!
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cleavage,! Aβ! is! invaginated! into!MVB! and! transported! to! the! plasma!membrane,!where! these! MVB! accumulate! at! the! synapses! of! neurons! and! disrupt! synaptic!transmission!(Almeida!et!al.,!2006).!!!As! well! as! the! ER! targeting! sequence,! fullSlength! APP! also! contains! a!mitochondrial! targeting! sequence,! and! was! first! discovered! to! localise! with!mitochondria! in! 1992! (Yamaguchi! et! al.,! 1992,! Park! et! al.,! 2004,! Chen! and! Yan,!2007).! APP! was! found! to! reside! with! its! NSterminus! embedded! in! the!mitochondrial!membrane!and!the!CSterminal!end!within!the!cytoplasm!of!the!cell!(Anandatheerthavarada!et!al.,!2003).!!This!may!signify!that!cleavage!of!APP!would!allow!for!the!release!of!Aβ!into!the!cell!cytoplasm!and!not!into!the!mitochondria.!!In!addition!to!localising!in!the!mitochondrial!membrane,!APP!was!also!shown!to!associate! with! the! import! machinery! of! the! mitochondria! (translocase! of! the!outer/inner! membrane,! TOM/TIM)! giving! rise! to! the! theory! that! APP! could!enhance! mitochondrial! dysfunction,! by! obstructing! these! pores!(Anandatheerthavarada!et!al.,!2003,!Lin!and!Beal,!2006).!!However,!the!smaller!Aβ!fragment! has! been! seen! to! accumulate! directly! within! the! mitochondria! and!therefore!due!to!the!orientation!of!the!APP,!questions!arose!of!how!does!Aβ!enter!the!mitochondria!and!what!effects!occur!due!to!its!presence?!!!
1.3 ALZHEIMER’S!DISEASE!AND!THE!MITOCHONDRIA!!
1.3.1!MITOCHONDRIAL!CONSEQUENCES!OF!INTRACELLULAR!AMYLOIDSβ!!As!indicated!above!Aβ!has!been!found!to!be!localised!both!in!the!mitochondria!of! human! AD! brains! and! in! AD! animal! models.! In! mutant! APP! transgenic! mice,!cortical!mitochondria!were! isolated! and! immunoblotting! carried! out,! the! results!showed! expression! of! Aβ40! and! Aβ42! in! comparison! to! control! mitochondria!(Manczak! et! al.,! 2006).! Additionally! Aβ! has! been! shown! to! accumulate! in! the!neuronal!mitochondria!of!AD!patients!(Caspersen!et!al.,!2005,!Hansson!Petersen!et!al.,!2008).!!
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!These!studies!suggest!that!Aβ!aggregation!occurs!within!the!mitochondria!and!both! found! evidence! of! metabolic! dysfunction! in! the! form! of! oxidative! damage,!increased!hydrogen!peroxide!(H2O2)!and!decreases!in!enzymes!of!the!respiratory!complexes! (e.g.! Cytochrome! c! oxidase! (COX))! as! a! result! of! Aβ! ! presence!(Caspersen! et! al.,! 2005,! Manczak! et! al.,! 2006).! Alongside! these! studies,! Aβ! was!found!to!coSlocalise!with!complex!II!of!the!electron!transport!chain!(ETC)!further!suggesting! that! Aβ! accumulates! and! possibly! interacts! in! the! mitochondria!(Tillement!et!al.,!2006,!Tillement!et!al.,!2011).!Due!to!the!orientation!of!APP!it!has!been!deemed!unlikely!that!cleavage!of!APP!occurs! to! release!Aβ!within! the!mitochondria! and! therefore,! Aβ!must! gain! entry!into! the!mitochondria! via! other! routes! (Lin! and!Beal,! 2006).! Evidence! for! direct!entry! into! the! mitochondria! provides! various! theories! for! access.! Aβ! has! been!found!to!permeabilize!through!lipid!bilayers!in!its!oligomeric!form!and!as!such!has!the! ability! to! pass! across! the! mitochondrial! membrane! by! exerting! effects! on!conductance!of!the!lipid!membrane!(Kayed!et!al.,!2004,!Glabe,!2006).!!This!relates!to!previous!findings!that!Aβ!is!most!toxic!in!the!oligomeric!form.!!Further! investigation! into! how! Aβ! enters! the!mitochondria! indicates! that! Aβ!uses!the!inherent!import!machinery!of!the!mitochondria.!A!neuroblastoma!cell!line!(SHSSY5Y)! was! used! to! detect! the! mitochondrial! internalisation! of! cytosolic! Aβ,!initially!confirming!that!Aβ!did!enter!the!mitochondria!from!the!cytosol!(Hansson!Petersen!et!al.,!2008).!Additional!experiments!showed!that!Aβ!was!dependent!on!the! TOM/TIM! machinery! to! gain! access! to! the! cristae! of! the! mitochondria!(Hansson!Petersen!et!al.,!2008).!This! is!now!the!most!widely!accepted!theory!for!Aβ!entry!into!the!mitochondria.!!!!!
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1.3.2!MITOCHONDRIAL!DYSFUNCTIONS!Mitochondrial! dysfunction! has! long! been! implicated! in! neurodegenerative!diseases! including! Alzheimer’s! disease! (reviewed! in! Borger! et! al.,! 2011).!!Mitochondria! are! the!main! source! of! energy! for! the! brain! and! as! such! there! are!very! high! numbers! present! in! neurons! (Pagani! and! Eckert,! 2011).! Neurons! are!very!particular!in!the!type!of!energy!substrates!they!use,!only!utilizing!glucose!and!ketone!bodies!to!produce!ATP!(Di!Paolo!and!Kim,!2011)!.!!During!normal!cellular!metabolism!the!final!step!of!energy!respiration,!the!ETC,!in! the! mitochondria! produces! small! amounts! of! reactive! oxygen! species! (ROS),!which!over!time!accumulate!and!can!generate!oxidative!stress!(Richter!et!al.,!1988,!Parker! et! al.,! 1994).! As! neurons! are! densely! packed!with!mitochondria! they! are!more! likely! to! have! naturally! higher! levels! of! ROS! thereby! increasing! their!susceptibility! to! oxidative! stress! and! consequently! increased! lipid! peroxidation!and!DNA!damage.!!Indeed!plasma! from!AD!patients! postSmortem,! have! shown! elevated! levels! of!the! toxic! aldehyde,! 4Shydroxynoneal! (4SHNE),! a! marker! for! lipid! peroxidation!(McGrath! et! al.,! 2001).! Living! AD! sufferers’! blood! samples! have! also! shown! a!significant! increase! in! another! toxic! aldehyde,! malondialdehyde! (MDA),! and! a!decrease! in! superoxide! dismutase! (SOD)! activity,! which! is! an! important! antiSoxidant! enzyme! (Padurariu! et! al.,! 2010).! These! findings! signify! a! disruption!between!the!delicate!balance!of!antiSoxidants!and!proSoxidants!which!result!in!the!protection!against!the!effects!of!increased!oxidative!stress!and!lipid!peroxidation.!!Oxidative! stress! is! thought! to! influence! the! morphology! and! dynamics! of!mitochondria.!Hirai!(2001)!described!several!abnormalities!in!mitochondria!from!AD! patients! linked! with! increases! in! oxidative! markers.! In! particular,! it! was!reported! that! there! were! significant! decreases! in! the! number! of! intact!mitochondria,! and! in! addition! there! were! significant! incidences! of! abnormal!mitochondrial! DNA! from! the! pyramidal! neurons! of! the! hippocampus! .! ! These!findings!have!been!mirrored!in!cybrid!cell!lines!from!AD!patients!or!controls!of!late!
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passage,! that! additionally! show! a! disruption! in! their! mitochondrial! membrane!potential,!indicating!that!the!cells!are!compromised!(Trimmer!et!al.,!2004).!!!As! well! as! the! oxidative! stress! and! mitochondrial! morphology! abnormalities!seen! in! AD! patients! there! are! also! changes! in! energy! production,!mitochondrial!protein!expression!and!key!mitochondrial!enzyme!activities.! !Alterations! in!brain!energy! metabolism,! in! particular! hypometabolism! are! seen! to! occur!asymptomatically! early! on! in! the! brains! of! AD! patients! (Cunnane! et! al.,! 2011).!!Investigating! changes! in! glucose! metabolism,! PET! scans! from! high! risk! AD!individuals! have! been! analysed! and! show! significant! areas! of! hypometabolism!particularly! in! the! parietal,! temporal! and! frontal! cortices! (Kennedy! et! al.,! 1995).!!There! are!many! theories! behind! this! decrease! in!metabolic! rate! ranging! from! a!reduction! in! the! numbers! of! glucose! transporters! (GLUT)! traversing! the! blood!brain!barrier,!through!to!alterations!in!glycolysis!(Arias!et!al.,!2002,!YurkoSMauro!et!al.,!2010).!Key!metabolic!enzymes!that!are!linked!to!mitochondrial!dysfunction!in!AD!are!αSketoglutarate! dehydrogenase! complex! (KGDHC),! pyruvate! dehydrogenase!complex!(PDHC)!and!COX!activity!(Gibson!et!al.,!1999,!Bubber!et!al.,!2005,!Fukui!et!al.,! 2007).! ! The! function! of! KGDHC! in! the! citric! acid! cycle! is! crucial! for! ATP!production,!its!close!proximity!to!the!ETC!has!produced!theories!that!the!ROS!that!are! produced,! could! affect! the! functioning! of! this! enzyme.!However,! studies! into!other! neurological! diseases! have! found! that! deficiencies! in! this! enzyme! could! in!fact!cause!oxidative!stress!(Albers!et!al.,!2000,!Blass,!2000).!!!Mitochondria!isolated!from!triple!transgenic!mice!(encoding!mutations!in!APP,!PSEN! and! Tau)! have! been! analysed! using! two! dimensionalSdifference! gel!electrophoresis!(2DSDIGE)!and!tandem!mass!spectrometry!to!profile!differences!in!mitochondrial!protein!expression!(Chou!et!al.,!2011).!The!findings!from!this!study!showed! the! downSregulation! in! specific! enzymes! involved! in! the! ETC,! such! as!NADH! dehydrogenase! which! acts! within! the! first! complex! of! ETC,! ! signifying!defects!in!ATP!production!(Chou!et!al.,!2011).!!One!of!the!three!components!of!the!enzyme! KGDHC! (dihydrolipoamide! succinyltransferase! component)! was! also!
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shown! to!be!upSregulated! in! comparison! to! controls,! implying!a!demand! for! this!enzyme!(Chou!et!al.,!2011).!Additionally,!many!studies!have!reported!a!decrease!in!levels!of!KGDHC,!hypothesising!that!the!effect!of!this!complex!within!the!citric!acid!cycle! are! consequently! reduced!which! results! in! a!decrease! in!metabolic! activity!(Chou!et!al.,!2011).!Studies!into!why!specific!regions!of!the!brain!degenerate!in!AD!have!used!a!computer!simulation!of!neuronal!networks!to!show!that!by!disrupting!the!KGDHC,!the!glucose!metabolic!rate!drops!but!only!in!excitatory!neurons!(Lewis!et! al.,! 2010).! The! theory! that! this! enzyme!may! cause! a! reduction! in! function! in!excitatory!neurons!is!noteworthy!as!the!areas!which!degenerate!in!AD!are!packed!with! primarily! excitatory! pyramidal! neurons.! However,! in! in) vitro! experiments!where! KGDHC! was! decreased! in! cell! lines,! these! cells! showed! increased!vulnerability!to!metabolic!insults!and!apoptosis!(Huang!et!al.,!2003).!As! well! as! the! reported! changes! to! the! ETC!within! the!mitochondria,! Aβ! has!been!reported!to!exert!its!toxicity!by!associating!with!other!components!within!the!mitochondria,! in! particular! two!mitochondrial! proteins;! amyloid! binding! alcohol!dehydrogenase!(ABAD)!and!Cyclophilin!D!(CypD).!These!proteins!appear!to!be!able!to!mediate!and!amplify!the!toxicity!of!the!Aβ!peptide.!Binding!of!both!proteins!to!Aβ40! and! Aβ42! has! been! demonstrated! at! nM! Aβ! concentrations,! and! Aβ!accumulation!within!cells!is!known!to!result!in!an!increase!in!expression!of!both!of!these!proteins!(Yan!et!al.,!1997,!Du!et!al.,!2008,!Du!et!al.,!2009).!
1.3.3!AMYLOIDS!β!BINDING!ALCOHOL!DEHYDROGENASE!!! Initially!ABAD!was!purified!from!bovine!liver!and!was!described!as!having!activity! reflecting! that! of! 3ShydroxyacylSCoA! dehydrogenase! (HADH),! an! enzyme!found! in! the! third! step! of! βSoxidation! of! fatty! acids! in! human! mitochondria!(Kobayashi! et! al.,! 1996).! ABAD! was! later! purified! from! rat! liver! and! classed! as!short!chain!LS3ShydroxyS2SmethylacylSCoA!dehydrogenase!(SCSHMAD)!(Luo!et!al.,!1995).!This!change!in!nomenclature!has!occurred!several!times!for!ABAD!as!it!has!been! discovered! from! different! mitochondrial! sources! and! utilising! different!substrates!(see!table!1.1!for!full!list!of!ABAD!identities).!!
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Figure! 1S2:! This! schematic! diagram! represents! the! oxidation/reduction! reaction!that!ABAD!catalyses!(Muirhead!et!al.,!2010a).!
Chapter)1:)Introduction)
16!!
1.3.3.1!Aβ!AND!ABAD!INTERACTION!ABAD,!was!initially!found!to!bind!to!Aβ!using!a!yeast!two!hybrid!screen!by!Yan!et!al.!(1997).!!In!the!same!study!it!was!seen!that!by!mutating!ABAD!the!toxic!effects!of! Aβ!were! prevented,! and! by! overSexpressing!ABAD,! Aβ! toxicity!was! increased.!Following!this!initial!discovery!Lustbader!et!al.)(2004)!confirmed!that!Aβ!directly!interacts! with! ABAD! and! furthermore! Aβ! binds! at! residues! 1S158! of! ABAD!(Lustbader!et!al.,!2004).!The!AβSABAD! interaction!was!crystallised! to! reveal! that!Aβ!binding!does!not!occur!with!the!presence!of!the!coSfactor!NAD!and!in!fact!the!binding!of!Aβ!to!ABAD!distorts!the!NAD!binding!site,!and!thereby!may!explain!the!reported!inhibition!of!ABAD!activity!(Lustbader!et!al.,!2004).!The!crystal!structure!of!ABAD!shows!three!secondary!protein!structures,!LF,!LE!and!LD!loops!(Figure!1.3),!a!particular!insertion!occurs!within!the!LD!loop!of!ABAD!which!is!lacking!in!other!short!chain!dehydrogenase/reductase!enzymes!(Lustbader!et!al.,!2004).!As!well!as!the!presence!of!the!unique!region!of!the!LD!loop,!it!was!reported!that!mutations!at!residues! 95S113! which! contain! the! LD! loop! prevent! the! interaction! of! Aβ! with!ABAD,! the! LD! loop! region!was! therefore! predicted! to! be! the! binding! site! for! Aβ!(Lustbader!et!al.,!2004).!!Lustbader!et!al.)(2004)!further!investigated!the!prediction!that!LD!loop!of!ABAD!bound!to!Aβ,!by!creating!a!peptide!containing!the!28!amino!acids!of!LD!loop,!called!ABADSdecoy!peptide!(ABADSDP),!and!this!decoy!peptide!was!subsequently!shown!by!surface!plasmon!resonance!(SPR)!to!bind!preferentially!to!Aβ!(Lustbader!et!al.,!2004).! In! addition,! when! this! peptide! was! fused! to! the! cell! membrane!permeabilising!TAT!peptide!then!this!prevented!Aβ!induced!cytochrome!c!release!in! primary! neurons! and! therefore! was! proposed! to! protect! the! Aβ! induced!disruption!of!ABAD!enzyme!activity(Lustbader!et!al.,!2004).!!!!!!
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In! summary! these! studies! showed! that! Aβ! binds! to! ABAD! preventing! its!enzymatic! function! by! distorting! the! binding! pocket! for! NAD.! Stopping! this! coSfactor’s! binding! halted! its! oxidation! and! reduction! reactions! consequently!potentially!affecting!metabolism,!fatty!acid!oxidation!and!ketone!body!production!within!the!mitochondria.!!!




toxic! aldehydes! 4SHNE! and! MDA.! The! overSexpression! of! wild! typeS! ABAD!(wtABAD)!and!mutated!APP!(mAPP)!within!COSS1!cell! lines!showed!a!significant!increase! in! both! 4SHNE! and! MDA! generation! implying! that! Aβ! overSexpression!with! ABAD! is! a! cause! of! toxicity! (Yan! et! al.,! 1999).! Interestingly! when! ABAD!activity! is! inhibited! by! two! substitution!mutations!made! between! residues! 168S172! (mutABAD)! and! expressed! with! elevated! levels! of! Aβ,! the! increase! in! toxic!aldehydes! did! not! occur,! and! the! cells! were! subsequently! protected! from! Aβ!toxicity!(Yan!et!al.,!1999).!These!results!along!with!the!knowledge!that!Aβ!binds!to!ABAD! suggest! that! an! accumulation! of! toxic! aldehydes! enhances! mitochondrial!dysfunction!and!that!the!reduction!in!the!metabolic!function!of!ABAD!consequently!causes!lipid!peroxidation.!Furthermore!ABAD!has!been!implicated!in!the!reduction!of! these! toxic! aldehydes! into! alcohols! suggesting! that! the! reduction! capacity! of!ABAD!is!inhibited!when!Aβ!is!bound!to!ABAD!(Murakami!et!al.,!2009).!!!!An! indication! that! the! AβSABAD! complex! affects! energy! production! has! also!been!reported!by!analysis!of!neurons!from!double!transgenic!mice!overexpressing!ABAD!and!Aβ.!Takuma!et)al)(2005)!report!significant!decreases!in!ATP!content!and!COX!activity!within!mitochondria!of!these!neurons!compared!to!single!transgenic!controls! (mAPP! ! or!ABAD! alone)! (Takuma! et! al.,! 2005).! ! COX! activity!within! the!ETC!is!a!vital!step!in!the!production!of!ATP!and!Takuma!et)al)(2005)!suggested!that!the! AβSABAD! complex! could! affect! the! activity! of! this! enzyme! consequently!decreasing!ATP!levels!(Takuma!et!al.,!2005).!!Consequences! of! the! AβSABAD! interaction! also! appear! as! changes! in! protein!levels! within! AD! brains.! Proteomic! analysis! of! brains! from! transgenic! mice!overexpressing!ABAD!and!Aβ!(Tg!mAPP/ABAD)!discovered!an!increase!in!the!antiSoxidant!protein,!Peroxiredoxin!2! (PrdxS2)(Yao!et! al.,! 2007).!PrdxS2!was! reported!by! western! blot! analysis! and! immunocytochemistry! to! be! present! in! cerebral!cortex! from!both! the! double! transgenic!mice! and!AD!patients! (Yao! et! al.,! 2007).!The! increased! expression! of! PrdxS2! in! the! presence! of! Aβ–ABAD! complex! was!suggested! to! be! a! protective! mechanism! in! response! to! increased! ROS! and!oxidative!stress.!Survival!assays!conducted!on!primary!cortical!neurons!expressing!a! plasmid! containing! PrdxS2!were! found! to! be! protected! from! toxic! levels! of! Aβ!
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(Yao!et!al.,!2007).!!Increased!antiSoxidant,!PrdxS2,!levels!in!response!to!Aβ!binding!to! ABAD! is! understood! to! attenuate! the! effects! of! elevated! oxidative! stress.! To!support! this,! reported! findings! from! hippocampal! tissue! from! PrdxS2! S/S! mice!showed! significant! increases! in! MDA! production! and! the! marker! for! oxidative!damage,!8Shydroxyguanosine!(8SOHG)(Kim!et!al.,!2011).!Further! proteomic! analysis! of! transgenic! mice! overexpressing! ABAD! and! Aβ!found! increased! expression! of! Endophilin! 1! (EpS1),! a! key! preSsynaptic! protein!which! acts! to!mediate! invagination! of! synaptic! vesicles! and! it! is! also! associated!with!cSJun!NSterminal!kinase!(JNK)!activity!(Schmidt!et!al.,!1999,!Ren!et!al.,!2008).!The!activation!of!JNK!is!linked!to!tumour!necrosis!factor!(TNFα)!induced!apoptotic!signalling! pathway! (Liu! and! Lin,! 2005).! Increased! expression! of! EpS1! in! Tg!mAPP/ABAD! mice! was! confirmed! by! immunocytochemistry! and! further!established! in! brain! tissue! from! AD! patients! by! western! blot! analysis! and!immunocytochemistry! (Ren! et! al.,! 2008).! Investigations! into! the! prediction! that!EpS1!contributes!to!JNK!activation!were!carried!out!in!HEK!293!cells!and!primary!cortical!neurons!by!western!blot!analyses;!when!EpS1!expression!is!increased!JNK!activity! increases,! furthermore! when! EpS1! is! truncated! the! activation! of! JNK! is!inhibited!(Ren!et!al.,!2008).!!!Therefore!the!increased!levels!of!PrdxS2!and!EpS1!are!good!indicators!of!the!AβSABAD! interaction.! Interestingly!when! the!AβSABAD!complex! is! interrupted! levels!of! these!elevated!proteins!decrease! to!endogenous! levels! signifying! the!cytotoxic!consequences!of!this!interaction!(See!below).!! 1.3.3.3!PREVENTING!Aβ!BINDING!TO!ABAD!The!binding!of!Aβ! to!ABAD!can!have!a!number!of! consequences! ranging! from!the!molecular! through!to! the!cellular!and!to! the!brain!as!a!whole.! ! It! is!generally!believed!that!by!inhibiting!the!AβSABAD!complex,!this!will!reduce!toxicity!with!the!cells!and!decrease!mitochondrial!dysfunctions.!!
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Creation!of!the!ABADSDP!fused!to!the!11!amino!acid!transduction!domain!from!human! immunodeficiency! virus!1Stransactivator! (HIVS1!Tat)! protein! allowed! the!decoy!peptide!to!be!used!in!primary!neuronal!culture!therefore!producing!a!novel!inhibitor!for!the!AβSABAD!complex!in)vitro)!and!in)vivo)(Lustbader!et!al.,!2004,!Yao!et!al.,!2011).!!!The! activation! of! JNK! by! EpS1! is! reported! to! significantly! reduce! neuronal!survival! but! interestingly! by! interrupting! the! interaction! between! Aβ! and! ABAD!with! the! HIVS1! TATS! ABADSDP,! EpS1! levels! are! decreased! back! to! endogenous!levels! (Ren! et! al.,! 2008).! Additionally,! the! increased! levels! of! PrdxS2! seen! as! a!consequence! of! AβSABAD! interaction! were! also! reversed! to! normal! levels! in! Tg!mAPP/ABAD! animals! in! the! presence! of! the! HIVS1! TATS! ABADSDP! (Yao! et! al.,!2007).!The! benefits! of! introducing! this! decoySpeptide! into! Tg!mAPP!mice! were! also!seen!as!an!intracellular!reduction!of!oxidative!stress!in!the!form!of!a!decreases!in!4SHNE! and! increasing! the! formation! of! ABADSDP–Aβ! complex! signifying! a!inhibition!in!the!ABADSAβ!interaction!(Yao!et!al.,!2011).!Encouragingly!the!in)vivo!effects! of! intraperitoneal! addition! of! ABADSDP! HIVS1! Tat! protein! into! Tg!mAPP!mice! showed! an! improvement! in! spatial!memory!when! tested!with! radial!water!arm!maze.!Furthermore!Aβ!accumulation!within!the!mitochondria!was!decreased!and! the! activity! of! the! Aβ! degradation! enzyme,! PreP,! was! increased! when!compared!with!ABADSDP!null!Tg!mAPP!mice!(Yao!et!al.,!2011).!!Other!inhibitors!of!the!ABADSAβ!complex!have!been!identified!such!as!the!small!molecule!inhibitor!classes!of!benzothiazole!ureas!e.g.!ThioflavinT!which!is!used!in!Aβ! imaging! (Xie! et! al.,! 2006).! As! well! as! these! potential! inhibitors,! the! crystal!structure!of!ABAD!with!NAD!allowed!for!the!creation!of!the!inhibitor!AG18051,!a!specific!inhibitor!for!ABAD!as!it!binds!coSvalently!with!NAD+!in!the!binding!pocket!of!ABAD!(Kissinger!et!al.,!2004,!Marques!et!al.,!2008).!This!inhibitor!has!been!used!
in) vitro! in! a! neuroblastoma! cell! line! (SKSNSSH)! to! show! inhibition! of! ABAD!(Muirhead!et!al.,!2010b).!However!the!inhibition!of!ABAD!by!blocking!its!active!site!
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would! not! be! predicted! to! be! a! realistic! protocol! in) vivo,! because! as! already!described,!the!disruption!of!ABAD!functioning!has!significant!consequences.!!1.3.3.4!MODULATION!OF!ABAD!ACTIVITY!The! consequence!of!Aβ!binding! to!ABAD! is! commonly! reported!as!a! complete!inhibition! of! the! enzyme! activity.! Within! the! majority! studies! this! is! shown! by!increased! production! of! ROS,! products! of! lipid! peroxidation! and! apoptosis! (see!above),!however!in)vivo!this!complete!inactivation!of!ABAD!may!not!be!the!case.!As!ABAD!has!multiple!substrates!it!could!be!suggested!that!the!presence!of!Aβ!could!alter!substrate!specificity.!!The!flexibility!of!ABAD!has!been!demonstrated!with!the!substrate!17β!estradiol.!!The! estrogen! receptor! alpha! (ERα)!was! found! to! coSlocalise! and! further! interact!with!ABAD! in!rat! cardiac!myocytes! (Jazbutyte!et!al.,!2009).!An! important! finding!was!discovered!by!coSimmunoprecipitation!of!ERα!with!ABAD!from!HELA!cells,!as!this! interaction! would! only! occur! when! intracellular! estrogen! levels! were! low!signifying! that! high! quantities! of! 17β! estradiol! were! present! (Figure! 1.4)!(Jazbutyte! et! al.,! 2009,! Yang! et! al.,! 2011).! This! reversible! binding! appears! to! be!influenced!by!the!levels!of!substrate!present!within!the!cell,!the!binding!of!ERα!to!ABAD!occurs!when!17β!estradiol!is!low!and!when!increased!binds!to!ERα!allowing!ABAD!to!metabolise!17β!estradiol!into!esterone.!The!binding!of!ERα!to!ABAD!could!allow!for!a!different!substrate!to!be!metabolised,!preferentially!when!17β!estradiol!levels!are!low.!The! finding! that! ABAD! is! involved! in! adapting! its! activity! under! changing!substrate! levels! provides! the! concept! that! ABAD! can! modulate! its’! substrate!specificity.!Initial!investigations!by!Shi!Du!Yan!et!al)(1999)!reported!that!ABAD!was!essential! for! the! toxic! effects! of! Aβ! to! occur! within! COS! cells,! in! comparison! to!expressing!ABAD!or!Aβ!alone!and!as!such!Aβ!affected!the!enzyme!function!of!ABAD!(Yan! et! al.,! 1999).! The! effect! of! increasing! the! nM! concentration! of! Aβ! on!ABAD!activity! was! reported! to! suppress! oxidation! of! 17βSestradiol! and! octanol! and!further!suppress!the!reduction!of!SSacetoacetylSCoA!(Yan!et!al.,!1999).!!!
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The!reduction!of!ABAD!activity!in!the!presence!of!Aβ!is!not!reported!as!a!complete!inhibition!of!ABAD!activity!but!a!slow!reduction!in!correlation!with!the!increase!of!Aβ! concentration.! These! results! suggest! that! Aβ! could! be! modulating! the!substrates! the! ABAD! uses! in! a! similar! way! that! low! levels! of! 17βSestradiol!modulates!the!binding!!of!ERα!to!ABAD.!!It!could!be!proposed!in!the!early!stages!of!AD,! when! Aβ! levels! are! low,! Aβ! acts! to! modulate! substrate! specificity! and! the!increasing! levels! of! Aβ! eventually! overwhelm! ABAD! activity! causing! oxidative!stress!and!lipid!peroxidation.! !! !!!!
1.3.4!CYCLOPHILIN!D!!The! family! of! proteins! called! Cyclophilin! were! originally! identified! as! the!intracellular! binding! proteins! for! the! immunosuppressive! drug! cyclosporine! A!(CsA)! (Handschumacher! et! al.,! 1984).! Cyclophilins! are! peptidylprolyl! isomerases!and!as!such!they!have!the!capability!to!catalyse!the!isomeration!between!cisJtrans)isomers! in! amino! bonds! containing! proline! in! order! to! aid! chaperone! protein!folding!(Tapparo!et!al.,!1999,!Giorgio,!2010).!Different!isoforms!of!Cyclophilin!were!characterised!and! found!to! localise!with! the!ER,! the!cytosol!and! in!particular! the!mitochondria! (Tapparo! et! al.,! 1999).!The!mitochondrial! isoform!of!Cyclophilin! is!
Figure!1S4:!A!schematic!diagram!of!the!modulation!of!ABAD!(17βHSD10)!under!varying! estrogen! levels.!When!E2! (17β! estradiol)! levels! are! low! the!ERα!binds!to! ABAD,! when! E2! levels! increase! the! ERα! is! disassociated! from! ABAD! and!binds!to!17β!estradiol!allowing!the!ABAD!activity!to!be!restored!(shown!by!the!oxidation!of!E2!to!E1!(estron))!(Jazbutyte!et!al.,!2009)!
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called!CypD!and!has!a!mitochondrial!preSsequence!at!the!NSterminal!(Connern!and!Halestrap,! 1992).!Within! the!mitochondria! immunohistological! staining! of! CypD!shows! coSlocalising! with! cytochrome! oxidase! in! the! mitochondrial! matrix!(Hazelton! et! al.,! 2009).! CypD! has! also! been! found! to! interact! with! the! inner!mitochondrial! membrane! (IMM)! under! periods! of! cellular! stress! (Connern! and!Halestrap,!1994).!CypD! from!rat! liver!mitochondria!was!shown!to!be! involved! in!the! formation! of! the! mitochondrial! permeability! transition! pore! (mPTP)! which!opens! under! cellular! stress,! in! this! case! oxidative! stress! induced! by! thiol! agents!(Connern!and!Halestrap,!1994).!!!1.3.4.1!THE!MITOCHONDRIAL!PERMEABILITY!TRANSITION!PORE!The! mPTP! is! reported! to! mediate! necrosis,! spontaneous! cell! death! and! have!some! involvement! in! apoptosis,! cell! death.! Spontaneous! cell! death! occurs! in!response!to!oxidative!stress!whereas!apoptosis!is!a!suicidal!process!requiring!ATP,!which!occurs!in!normal!cell!turnover!(Majno!and!Joris,!1995).!!!Initial!reports!of!the!mPTP! describe! heart!mitochondria,! as! open! and! leaky! under! conditions! of! high!calcium! levels! and! oxidative! stress! (Crompton,! 1987).! Further! investigations!showed! that! in!periods!of! cellular! stress! and!high! intracellular!Ca2+! levels!mPTP!formation!occurs!and!subsequently!opens.!Pore!opening!allows!small!molecules!to!pass! across! the! outer! and! inner! membranes! of! the! mitochondria! and! into! the!mitochondrial!matrix! (Halestrap,! 2005).! This! flux! causes! a! depolarization! of! the!membrane! (altering! the!membrane!potential),! increasing! the!permeability!of! the!inner! membrane! and! disrupting! ion! homeostasis! (Schinzel! et! al.,! 2005).!Consequently!the!mitochondria!swell!and!the!membranes!eventually!rupture.!It!is!hypothesised!that!with!prolonged!opening!of!the!mPTP!necrosis!occurs!as!ATP!is!depleted!but!if!the!mPTP!closes!cytochrome!c!is!released!which!initiates!apoptosis!of!the!cell!(Schinzel!et!al.,!2005,!Halestrap,!2005).!!!!!
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1.3.4.1.1)mPTP)COMPOSITION)The! mPTP! has! been! hypothesised! to! contain! 3! main! components:! CypD,! the!adenine! nucleotide! translocase! (ANT)! and! the! voltage! dependent! anion! channel!(VDAC)!(Figure!1.5).!!!!
The!transmembrane!protein,!ANT,!spans!the!IMM!and!its!endogenous!function!is!to!drive!transportation!of!ATP!and!ADP!(Machida!et!al.,!2002).!The!importance!of!ANT!within!the!mPTP!is!reviewed!thoroughly!by!Halestrap!and!Brenner!(2003);!in!summary,! increased!oxidative!stress!present! in!neurons! is! reported! to!alter!ANT!by! glutathioneSmediated! crossSlinking! of! two! cysteine! residues! which!consequently! inhibits! endogenous! activity! of! ADP! binding! and! increases! CypD!binding!(Halestrap!and!Brenner,!2003).!!The!binding!of!CypD!to!ANT!is!supported!by! the!observation! that!when!external!oxidative!stress!was!applied! to!cells,! then!CypD! translocated! to! the! IMM! where! it! was! initially! suggested! to! bind! to! an!integral!membrane!protein!(Connern!and!Halestrap,!1994).! !It!is!now!known!that!CypD! interacts! with! ANT! in! the! IMM,! as! CypD! was! purified! from! rat! liver!mitochondria!and!found!bound!to!the!IMM!(Woodfield,!1998).!The!significance!of!CypD!translocation!and!binding!by!exerting! isomeration!of!cisStrans! isomers!at!a!proline!residue!to!ANT!is!reported!to!mediate!the!high!levels!of!Ca2+!which!results!
Figure!1S5:!Mitochondrial!permeability! transition!pore,!when!open!allows!solutes!and!water! to! flux! into! the!mitochondria! initially!giving!rise! to!an! increase! in!ROS!then!mitochondrial!swelling!and!cytochrome!c!release(Halestrap!et!al.,!2002).!
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in! a! conformational! change! of! ANT! to! a! nonSspecific! ‘open’! pore! (Halestrap! and!Brenner,!2003,!Halestrap,!2005).!!! ! !Along!with! the! interaction! of!ANT!with!CypD,! Crompton!et) al) (1998)! purified!CypD,!and!found!that!VDAC!and!ANT!were!bound!to!CypD(Crompton!et!al.,!1998).!!VDAC! is! a! voltage! dependent! transmembrane! pore! that! spans! across! the! outer!mitochondrial!membrane!(OMM).!!The!importance!of!VDAC!as!part!of!the!mPTP!is!still!in!debate,!as!it!has!been!reported!to!have!a!superfluous!role!but!has!also!been!shown!to!interact!with!ANT!allowing!pore!formation!and!opening!(Krauskopf!et!al.,!2006).!VDAC!was!determined!to!not!be!the!site!for!mPTP!inhibition!but!could!still!play! a! role! as! an! OMM! component! of! the! mPTP.! Recent! studies! have! reported!further! OMM! components! that! could! regulate! the! IMM! pore,! such! as! the!translocator! protein! (TSPO)! and! the! phosphate! carrier! (PiC)! (Halestrap! and!Brenner,!2003,!Krauskopf!et!al.,!2006,!Sileikyte!et!al.,!2011).!It!could!be!suggested!that! different! OMM! proteins! could! regulate! permeability! transition! but! that! the!crucial!factor!of!transition!is!CypD.!!!Analyses! of! the! three! main! components! reported! to! form! the! mPTP,! has!determined!that!CypD!is!an!essential!component!of!the!mPTP,!facilitating!necrosis.!!CypD! has! previously! been! suggested! to!mediate! necrosis! as! a! component! of! the!mPTP,!by!binding!to!ANT!and!accelerating!the!Ca2+!induced!conformational!change!of! ANT! (Halestrap! and! Brenner,! 2003).! To! investigate! the! role! of! CypD! and!consequently!the!mPTP!in!apoptosis!and!necrosis,!CypD!deficiency!was!studied.!!In!the!absence!of!CypD,!murine!embryonic!fibroblast!(MEF)!cells!(cultured!from!CypD! deficient! (CypDJ/J)! mice)! were! still! reported! to! undergo! apoptosis! after!insults!from!TNFα!and!staurosporin!(Nakagawa!et!al.,!2005).!However,!when!pore!opening!was!initiated!by!the!addition!of!H2O2,!causing!ROS!production,!no!adverse!effects! on! the!MEF! cells!were! reported! (Nakagawa!et! al.,! 2005).!Additionally! the!membrane! potential! of! these! CypD! deficient! cells! was! resistant! to! excess! Ca2+!(Nakagawa! et! al.,! 2005).! These! results! suggest! that! CypD! is! absent! from! the!apoptotic! pathway! but! is! essential! in! mediating! the! necrotic! consequences! of!oxidative! stress! and! increased! calcium! levels.! Apoptotic! stimulation! failed! to!
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induce!apoptosis! in!CypD!deficient!MEF!cells! suggesting! that! the!mPTP!does!not!play!an!important!role!in!apoptosis!but!it!appears!to!be!necessary!for!necrosis!to!occur! (Nakagawa! et! al.,! 2005,! Halestrap,! 2005).! The! hypothesis! that! CypD! is!essential!in!mPTP!formation!and!specifically!in!facilitating!necrosis!over!apoptosis!is! supported! by! the! finding! that! transgenic! mice! overSexpressing! CypD! were!particularly! sensitive! to! mitochondrial! swelling! and! remarkably! showed!spontaneous!cell!death!(Baines!et!al.,!2005).!!!1.3.4.2!Aβ!AND!CYCLOPHILIN!D!As!was!found!with!ABAD!the!expression!of!CypD!is!altered!in!AD!patient!brains,!specifically!CypD!is!elevated!in!mitochondria!from!the!hippocampus!and!temporal!cortex! (Chen! and! Yan,! 2010).! CypD! was! also! found! to! be! increased! in! the!mitochondria! from! the! hippocampus! of! transgenic! mouse! models! for! AD! overSexpressing!Aβ!(Tg!mAPP)!(Du!et!al.,!2008,!Chen!and!Yan,!2010).!!Following!this,!the!binding!of!Aβ!to!CypD!was!investigated,!and!results!from!SPR!revealed!that!indeed!Aβ!did!bind!to!CypD!and!especially!with!higher!affinity!to!Aβ42!and!Aβ!oligomers!(Du! et! al.,! 2008).! CypD! and! Aβ! were! also! seen! to! coSlocalise! and!immunoprecipitation! studies! carried! out! showed! that! the! CypDSAβ! complex!occurred!in!mitochondria!from!AD!brains!(Du!et!al.,!2008).!It!is!also!interesting!to!note! that! simulations! of! proteinSprotein! interactions! hypothesised! that!Aβ! could!bind!to!CypD!and,!interestingly,!also!to!ANT!with!a!higher!affinity!suggesting!that!binding!is!energetically!favourable!(Singh!et!al.,!2009).!!The!main!consequence!of!CypD!binding!to!Aβ!is!an!increase!in!ROS!production,!which! in! turn! initiates! mPTP! opening! and! subsequently! necrosis.! However,! the!effects! of! this! interaction! have! been! reported!when! CypD! is! absent.! Specifically,!transgenic!mice! overexpressing! Aβ! (Tg!mAPP)! and! CypD! deficient!were! seen! to!mitigate! the! effects! of!mitochondrial! swelling,! increased!membrane!permeability!and!Cytochrome!C!release,!all! reported!when!Aβ! is!present!with!CypD!(Du!et!al.,!2008).! !The!consequence!of!Aβ! interacting!with!CypD! to! instigate!mPTP!opening!can! be! evaluated! by! the! mitochondrial! calcium! retention! capacity! (CRC),! which!determines! the! likelihood! of! mPTP! formation.! NonStransgenic! mice! are! seen! to!
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1.4!METABOLOMICS!AND!LIPIDOMICS!IN!ALZHEIMER’S!DISEASE!BRAIN!!The!consequences!of!Aβ!accumulation!within!the!mitochondria!can!provide!an!explanation! for! the! well! noted! problems! associated! with! metabolism! in! AD!patients.!The!mitochondria! are! essential! in! regulating! energy!within! cells! and!as!previously! mentioned! consequences! of! their! dysfunction! appear! as! oxidative!stress,!increased!ROS!production!and!lipid!peroxidation.!In!addition!to!the!cellular!stress!caused!by!mitochondrial!dysfunction!in!AD,!decreased!energy!metabolism!is!also!very!prevalent!(Atamna!and!Frey,!2007).!It!is!important!to!note!that!decreases!in!energy!metabolism!are!also!seen!in!aging!brains,!but!hypometabolism!is!much!more!pronounced!in!AD!(Bentourkia!et!al.,!2000).!The!reason!for!hypometabolism!in! the! AD! brain! are! largely! unknown,! though! some! events! are! known! such! as!alterations! in! the! respiratory! chain! enzymes,! changes! in! glucose! transport,! the!presence! of! Aβ! within! the! mitochondria! and! changes! in! lipid! membrane!composition!are!all!known!to!be!involved.!!!
1.4.1!GLUCOSE!METABOLISM!Glucose! enters! the! brain! via! glucose! transporters! (GLUTs),! and! in! this! way!GLUTs! are! very! valuable! for! providing! the! correct! levels! of! glucose! and!consequently! the! energy! levels! in! neurons.! The! three!main! GLUTs! that! regulate!glucose!entry!into!the!brain!are!GLUT1!which!facilitates!glucose!across!the!blood!brain!barrier,!GLUT2!which!is!present!in!astrocytes!and!allows!for!glucose!storage!via! slow! glucagon! release,! and! finally! GLUT3! which! transports! glucose! into!neurons! for! the! first! step! of! ATP! production! (Marty! et! al.,! 2005,! Cunnane! et! al.,!2011).! !The!three!stages!of!energy!production!are!glycolysis,!citric!acid!cycle!and!the!electron!transport!chain.!Glycolysis!is!where!glucose!is!converted!to!pyruvate!
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and! acetyl! CoA!which! feeds! into! the! citric! acid! cycle! (Stryer,! 1995).! In! the! citric!acid! cycle! fatty! acids,! amino! acids! and! carbohydrates! undergo! oxidative!degradation!and!are! fed! into! the! electron! transport! chain! is!where!electrons! are!transferred!in!order!to!synthesis!ATP!(Stryer,!1995).!Metabolic! changes! in! glucose! have! long! been! associated! with! aging! and! AD.!Initially,!age!related!changes!in!glucose!metabolism!were!noted!in!aged!rat!models.!It!was! reported! that! specific! regions!of! the!brain! such!as! the!hippocampus! (CA1!and!CA3)!and!prefrontal!cortex,!showed!significant!decline!in!glucose!metabolism!(Gage!et!al.,!1984).! ! In!addition,!difficulties! in! learning!and!memory!were!seen!to!correlate!with! the! decline! of! glucose!metabolism! in! these! aged! rats! (Gage! et! al.,!1984).!This!finding!implied!that!a!reduction!of!glucose!utilisation!can!occur!in!the!aged!brain.!!!In!conjunction!with!the!reduction!of!glucose!metabolism,!aged!rats!subjected!to!hypertension!were! ! reported! to! show!reduced! cerebral! glucose!utilization! in! the!hippocampus!and!cerebral!cortex!along!with!impairments!in!learning,!highlighting!the! importance!of! a!healthy!diet! and!exercise! in!old!age! (Mori! et! al.,! 1995).!This!could!suggest!that!hypertension!in!AD!patients!could!exacerbate!the!reduction!of!glucose!utilisation.!The!metabolic!rate!for!glucose!was!measured!in!young!and!old!participants! and! a! significant! decrease! was! reported! in! the! elderly! participants!(Bentourkia!et!al.,!2000).!It!was!reported!that!in!normal!aging!a!decrease!of!13.3%!in! glucose! utilisation! occurs! along! with! a! degeneration! of! 12%! of! hippocampal!neurons,! in! comparison! AD! sufferers! are! reported! to! lose! 57%! of! hippocampal!neurons!(Bentourkia!et!al.,!2000,!Sakamoto!et!al.,!2002).!!
MEASURING)HYPOMETABOLISM)IN)THE)AD)BRAIN)Oxygen!metabolism,! glucose! utilization! and! cerebral! blood! flow! have! all! been!seen! to! decrease! in! AD! brains! (Ishii! et! al.,! 1996).! ! In! order! to! observe! these!changes,! in! particular,! the! reduction! of! glucose! utilisation! in!AD!brains,! positron!emission! tomography! (PET)! imaging! is! used.! PET! detects! biologically! active!materials!within!the!brain;!(18F)!Fluorodeoxyglucose!(FDG)!is!primarily!used!as!the!
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radioactive!tracer!in!glucose!investigations!as!it!is!a!derivative!of!glucose!and!is!up!taken!by!the!brain!in!a!similar!manner!(Muehllehner!and!Karp,!2006).!!PET! scans! uniformly! describe! hypometabolism! in! the! AD! brain,! localising!specifically! in! regions! known! to! degenerate! in! AD! e.g.! the! temporal! lobe!(Desgranges! et! al.,! 1998,! Li! et! al.,! 2008).! Within! the! temporal! lobe,! the!hippocampus! is! reported! to! show! reduced! cerebral! metabolic! rate! of! glucose!(CMRg)! early! on! in! AD! disease! and! following! this! other! regions! of! the! temporal!lobe! such! as! the!medial! temporal! lobe! show! decreases! in! CMRg! too! (Ishii! et! al.,!1996,!Cunnane!et!al.,!2011).!These!areas!are!particularly!involved!in!the!processing!of!memory.!Understandably,!low!CMRg!in!these!regions!would!lead!to!difficulties!in!storing!and!retrieving!memories,!the!key!problem!associated!with!AD.!!!!The!temporal!lobe!shows!hypometabolism!before!the!parietal!and!frontal!lobes!in! AD! brains,! why! this! is,! is! unclear.! However,! studies! into! the! effects! of! Aβ! on!CMRg!in!AD!have!been!investigated.!To!facilitate!the!imaging!of!Aβ!a!unique!type!of!PET!can!be!used;!Pittsburgh!compound!B! (PIB)! is! a! fluorescent!derivative!of! the!dye!benzothiazole!thioflavin!T!and!is!used!for!its!binding!capability!with!Aβ!and!its!ability!to!cross!the!blood!brain!barrier!(Klunk!et!al.,!2004).!It!can!be!imaged!using!PET! and! so! PIBSPET! measures! aggregated! Aβ! fibrillar! deposition! in! the! living!brain.! In! contrast! to! regions! of! brain! degeneration! and! hypometabolism,! PIB!detects!the!areas!of!late!stage!Aβ!plaque!accumulation.!When!comparing!PET!and!PIBSPET! scans! from! the! Hippocampus! of! AD! sufferers,! there! are! unexpected!findings.!Only! small! deposits! of!Aβ! are! seen,!whereas! the!CMRg! is! reduced,! thus!implying! that! there! is! no! link! between! Aβ! deposition! and! decreases! in! glucose!utilisation.! PIBSPET! also! showed! retention! in! the!middle! frontal! gyrus,! posterior!cingulate! cortex! and! inferior! parietal! lobe! while! FDGSPET! detected!hypometabolism!in!very!different!areas!of!the!brain!(Li!et!al.,!2008).!These!results!were!confirmed!in!further!PET!and!PIBSPET!investigations!of!AD!patients!where!it!was! concluded! that! amyloid! plaques! and! the! loss! of! glucose!metabolism! do! not!correlate!(Furst!et!al.,!2010).!The!dye!used!in!PIBSPET!scanning!could!provide!an!explanation!as!thioflavinT!will!only!bind!to!specific!Aβ!fibrils!and!therefore!not!all!Aβ!forms!will!show!in!this!type!of!analysis,!rendering!it!somewhat!misleading.!
Chapter)1:)Introduction)
31!!
EFFECT)OF)Aβ)ON)HYPOMETABOLISM)Studies! have! shown! that! accumulation! of! Aβ! within! neurons! could! have! an!effect! on! energy! metabolism! specifically! on! the! transportation! of! glucose! to!neurons! for! ATP! generation.! The! presence! of! Aβ! in! hippocampal! and! cortical!neuronal!cultures!has!been!observed!to!impair!glucose!transport.!Furthermore,!it!was!seen!that!the!decrease! in!glucose!was!enough!to!cause!reductions! in!cellular!ATP! levels! (Mark! et! al.,! 1997).! Additional! studies! in! mice! overSexpressing! Aβ,!showed!that!early!changes!in!metabolism!occur!in!regions!of!the!brain!such!as!the!parietal!cortex!and!thalamus!whereas!older!mice!show!further!hypometabolism!in!the! hippocampal! region! CA3! (Dodart! et! al.,! 1999).! In) vivo) investigations! of!cerebrospinal! fluid! (CSF)! from!AD!patients! also! showed! a! significant! correlation!with! decreased!metabolic! glucose! rate! in! the! brain! and! decreased! levels! of! Aβ42!compared!to!nonSAD!control!patients!(Okamura!et!al.,!1999).!These!results!provide!a! connection! between! the! reduction! of! Aβ42! in! CSF! with! decreased! glucose!utilisation! in! the! AD! brain,! implying! that! as! decreased! CMRg! indicates! neuronal!loss!the!decreased!levels!of!Aβ42!will!reflect!this!loss.!!As! previously! noted! the! accumulation! of! Aβ! has! been! observed! to! induce!oxidative!stress!within!AD!neurons!and!products!of!this!oxidative!stress!have!been!reported! to! be! involved! in! the! reduction! of! CMRg.! 4SHNE! is! produced! as! a!consequence!of!oxidative!stress!and!Mark!et!al.)(1997)!found!that!4SHNE!acts!as!a!direct! instigator!of!hypometabolism!more! than!other! lipid!peroxidation!products!(Mark! et! al.,! 1997).! Evidence! from! immunoprecipitation! investigations! from!hippocampal! neuronal! cultures! implied! that! Aβ! initiates! 4SHNE! conjugation! to!GLUT3,!and!consequently!it!was!described!as!a!possible!route!for!hypometabolism!via! oxidative! stress! caused! by!Aβ! (Mark! et! al.,! 1997).! Astrocytes! have! also! been!seen! to!be!affected!by! the!presence!of!Aβ!as!glutamate!and!glucose!uptake!were!significantly!reduced,!and!so!it!was!suggested!that!the!reduction!of!glucose!uptake!in!astrocytes!could! lead!to!a!decrease! in!the!storage!of!glucose!and!consequently!affect!long!term!usage!of!glycogen!stores!(ParpuraSGill!et!al.,!1997).)))
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The! GLUTs! are! very! important! for! regulating! the! levels! of! glucose! available!within!the!brain!and!decreases!in!glucose!metabolism!could!therefore!be!due!to!a!reduction! in! glucose! presence.! Research! supporting! this! shows! a! reduction! in!GLUT1!expression!in!the!hippocampus!of!Tg!mAPP!mice!(Lauderback!et!al.,!2001).!!In! addition! to! the! previous! finding! that! lipid! peroxidation! in! astrocytes! blocks!GLUT3,!another!study!has!found!that!GLUT1!is!inhibited!by!an!interaction!with!4SHNE!(Lauderback!et!al.!2001).!Hence!the!presence!of!Aβ!induces!lipid!peroxidation!and!as!such!reduces!the!intake!of!glucose!into!neurons!via!GLUT1.!As!well!as!the!effect!of!Aβ!on!glucose!transportation,!Aβ!induced!oxidative!stress!has!been!reported!to!affect!ATP!via!alterations! in!glycolysis.!Pereira!et!al.! (1999)!investigated!pyruvate!levels!in!PC12!cells!to!find!that!in!the!presence!of!Aβ!levels!of!pyruvate!were!significantly!decreased!.!Reduced!levels!of!pyruvate!suggest!that!the!conversion!of!glucose!to!pyruvate!in!glycolysis!is!compromised!by!the!presence!of!Aβ.! In! addition,!Aβ!was!observed! to! inhibited! complexes! I,! IISIII! and! IV!of! the!electron! transport! chain! as! a! decrease! in! each! complex’s! activity! was! observed!(Pereira!et!al.,!1999).! Interestingly!the!activity!of!each!complex!was!substantially!recovered!by!the!addition!of!antioxidants!signifying!that!the!decline!in!activity!was!a!consequence!of!oxidative!stress.!!Collectively! these! findings! suggest! that! Aβ! is! involved! in! the! decreased! CMRg!observed! in!AD.!When! the! levels!of!glucose!start! to!decrease! in!neurons!another!energy!source!is!required,!as!neurons!cannot!utilise!fatty!acids!directly,!they!must!be!metabolised! to! ketones! for! use! in! the! citric! acid! cycle! and! subsequently! ATP!production!(Di!Paolo!and!Kim,!2011)!.!
1.4.2!LIPID!METABOLISM!Lipid! metabolism! includes! cholesterol! production,! steroid! generation! and!specifically! the! breakdown! of! fatty! acids,! to! be! used! as! an! alternative! fuel! to!glucose.!Under!periods!of!starvation,!hypoglycaemia!can!occur!and!the!brain!must!use! other! sources! for! energy! production! (Di! Paolo! and! Kim,! 2011).! The! brain!cannot! use! fatty! acids! themselves! only! ketone! bodies! and! glucose! (Di! Paolo! and!
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Kim,!2011).!Therefore,!fatty!acids!are!released!from!adipose!tissue!and!oxidised!in!three! steps,! the! last! of! which! is! controlled! by! the! 3ShydroxyacylSCoASdehydrogenase! enzyme! ABAD.! Ketone! bodies! such! as! DSβShydroxybutyrate! and!acetoacetate! are! produced! as! bySproducts! of! these! reactions.! ! Derivatives! from!ketone!bodies!feed!into!the!citric!acid!cycle!at!different!points!in!order!to!produce!ATP!(Kashiwaya!et!al.,!2000).!!This!alternative!source!of!fuel!is!essential!in!AD!due!to! the! reduction! in! glucose! uptake.! It! is! interesting! to! note! that! ABAD! is! up!regulated!in!AD!and!therefore!could!be!under!high!demand!if!ketones!are!the!main!source!of!fuel!in!AD!(Lustbader!et!al.,!2004).!Therefore,!Aβ!could!be!hypothesised!to! have! a! twoSpronged! attack! on! energy!metabolism! by! initially! reducing! CMRg!and!compromising!the!alternative!energy!source!by!impairing!ABAD!activity.!!
USE)OF)KETONE)BODIES)AS)AN)ALTERNATIVE)ENERGY)SOURCE)Products!of!fatty!acid!metabolism,!ketone!bodies,!such!as!DSβShydroxybutyrate!and!acetoacetate!have!been!seen! to!attenuate! the!effects!of!hypometabolism!and!are! thought! to! protect! neurons! in! AD! by! providing! an! alternative! route! to! ATP!production.!!!The!use!of!ketones!in!the!brain!could!have!therapeutic!properties!as!they!may!be!sufficient!to!buffer!the!effects!of!Aβ!in!AD!as!the!following!studies!have!seen!the!addition! of! ketones! to! AD! models! have! beneficial! effects.! For! example,!hippocampal!neurons!treated!with!Aβ42!were!rescued!from!toxicity!by!the!addition!of! DSβShydroxybutyrate.! This! beneficial! effect! of! ketones! was! explained! by! the!bypassing! of! glycolysis! or! by! the! activation! of! a! pathway! that! leads! to! the!phosphorylation!of!PDHC!(Kashiwaya!et!al.,!2000).!The!finding!that!high!levels!of!ketones! protect! cells! suggests! that! a! diet! high! in! ketones! could! be! used! as! a!therapeutic! measure! to! prevent! hypometabolism! in! neurons.! Following! this,! Tg!mice!expressing!Aβ40!and!Aβ42!that!were!put!on!a!ketogenic!diet,!consisting!of!low!carbohydrates!and!high!fat!induced!a!ketogenic!state,!and!resulted!in!a!significant!reduction! of! Aβ40! and! Aβ42! levels! (Van! der! Auwera! et! al.,! 2005).! ! The! effects! of!introducing! excess! ketones! into! the! body! to! counteract! glucose! deficiency,! has!proven!to!be!successful!even!in!clinical!trials!(Reger!et!al.,!2004,!Henderson,!2008).!!
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! The! addition! of! the!medium! chain! triglyceride,! DSβShydroxybutyrate,! into! the!diet! of! 20! participants! with! AD! showed! a! significant! improvement! in! memory!(Reger!et!al.,!2004).!!DSβShydroxybutyrate!allows!the!initial!steps!of!the!citric!acid!cycle! to! be! bypassed! along!with! avoiding! the! oxidation! of! free! fatty! acids! in! the!body.!Furthermore,!recent!clinical!trials!in!the!USA!have!induced!a!ketogenic!state!within! AD! patients! to! try! and! reverse! the! effects! of! hypometabolism.! By!introducing!an!oral!ketogenic!compound,!ACS1202,!into!their!diet!the!levels!of!DSβShydroxybutyrate!increased!in!their!serum!and!significant!cognitive!improvements!were! observed! (Henderson,! 2008).! The! use! of! ketone! bodies! is! therefore! now!being!seen!as!a!potential!suitable!therapy!in!AD;!however,! the!effects!of! inducing!ketogenesis! on! Aβ,! hyperphosphoyrlated! tau! production! and! lipid! granule!accumulation!in!AD!are!yet!to!be!studied.!!!!Collectively! these! findings! could! propose! a! route! for! declining!metabolism! in!AD,!because!Aβ!may!exert!effects!within!the!early!reactions!of!the!citric!acid!cycle!and! the! external! addition! of! ketones! can! feed! into! the! cycle! and! so! attenuate!hypometabolism.!Alternatively!the!knowledge!that!ABAD!works!in!the!βSoxidation!of!fatty!acids!to!produce!ketone!bodies,!infers!that!the!inhibition!of!this!enzyme!by!Aβ,!could!consequently!reduce!both!ATP!from!fat!stores!and!the!essential!supply!of!ketone!bodies.!!Other!areas!of!lipid!metabolism!seem!to!be!effected!in!AD!such!as!decreases!in!omegaS3!fatty!acids!reported!post!mortem!in!AD!brains!and!additionally!with!the!knowledge! that! hypometabolism! occurs! in! AD,! fatty! acid! metabolism! must! be!affected!too!(Freemantle!et!al.,!2006,!Cole!et!al.,!2009).!!Reduction! in! the! omegaS3! fatty! acid,! docosahexaenoic! acid! (DHA),! has! been!linked!to!regulations!of!GLUT1!expression!and!consequently!glucose!uptake!in!rat!endothelial! brain! cells! (Pifferi! et! al.,! 2010).! ! Investigation! into! rat!models! of! AD!given! DHA! significantly! found! that! in! addition! with! improved! memory! and!learning,! a! reduction! in! oxidative! stress! and! lipid! peroxidation! was! observed!(Hashimoto! et! al.,! 2002).! DHA! has! been! reported! to! increase! the! fluidity! of!membranes,!and!from!previous!research!it!can!be!concluded!that!this!will!reduce!
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the!generation!of!Aβ!via!the!amyloidogenic!processing!of!APP!(FlorentSBechard!et!al.,! 2009).! ! It! can! be! deduced! from! these! results! that! membrane! fluidity! and!consequently! lipid! composition! of! neurons! is! of! extreme! importance! in! the!production!of!Aβ.!In! summary,! the! decreasing! glucose! metabolism! in! AD! is! attributed! to! the!interference! of! GLUTs! and! glycolysis! by! oxidative! stress,! which! is! caused! by! Aβ!accumulation.!The!low!levels!of!glucose!have!a!knockSon!effect!on!the!utilisation!of!alternative!energy!sources!used!by!the!brain!by!demanding!high! levels!of!ketone!bodies.! Inhibition! of! the! ketone! production! pathway!will! result! in! the! brain! not!receiving!enough!fuel!and!consequently!cause!cells!to!die.!Reductions!in!the!brain!of!essential! fatty!acids!such!as!DHA!induce!Aβ!production!and!in!turn!reduce!the!availability!of!an!alternative!brain!fuel.!)

















2.1.1!POLYMERASE!CHAIN!REACTION!(PCR)!PCR! was! performed! to! clone! three! constructs,! in! a! 25µl! reaction! volume!containing! PfuTurbo! DNA! polymerase! (Agilent! Technologies,! Berkshire)! with!appropriate! 10x! cloned! Pfu! buffer! (supplied! by! Aigilent),! 200µM! dNTPS!(Roche)(for! PfuTurbo! reactions! or! ReadyMix! Taq! PCR! reaction! mix! with! MgCl2!(SigmaSAldrich)!10µM!of!forward!and!reverse!primers!(Invitrogen)!and!25S100ng!template! DNA.! PCR! reactions! were! carried! out! in! a! BioSRad! Gradient! Thermal!Cycler!(BioSRad,!UK)!thermal!PCR!cycle!is!described!in!table!2.1.!!Table! 2S1:! PCR! cycle! temperatures! and! corresponding! times.! Denaturing! of! DNA!occurs!at!94oC,!annealing!of!primers! is!dependent!on!the!primer!composition!and!Tm!and!varies!with! each!PCR! (occurring! at! χoC)! and!elongation!of!DNA!occurs! at!72oC.!!!
Temperature! Time!(sec)!94oC! 180!94oC! 40!χoC! 50!72oC! 90!72oC! 600!4oC! ∞!!
2.1.2!AGAROSE!GEL!ELECTROPHORESIS!DNA!fragments!were!run!and!separated!on!1%!(w/v),!1.5%!(w/v)!or!2%(w/v)!agarose!gel,!depending!on!fragment!size.!DNA!smaller!than!1kb!was!run!on!a!1%!gel,! for! DNA! fragments! between! 1S2kb! were! run! on! a! 1.5%! gel! and! fragments!larger!than!2kb!were!run!on!a!2%!gel.!The!appropriate!agarose!was!melted!in!TBE!
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buffer! (0.45M! TrisSborate! 10mM! EDTA,! pH! 8.3,! Sigma)! and! once! cool! ethidium!bromide! (Sigma)! was! added! to! a! final! concentration! of! 0.5µg/ml.! Agarose! plus!ethidium!bromide!was!poured!in!a!rig!and!left!at!room!temperature!for!20!minutes!to!set.!DNA!samples!were!prepared!by!adding!5x!loading!buffer,!blue!(Bioline)!and!once! the! gel! was! set! added! into! the! gel! wells.! HyperLadder! I! (Bioline)! was! run!concurrently!in!order!to!analyse!DNA!band!size.!The!agarose!gel!was!run!at!65V!for!45!minutes!and!detected.!
2.1.3!PURIFICATION!OF!DNA!FRAGMENTS!FROM!AGAROSE!GEL!DNA! was! visualized! using! a! UV! transilluminator! (Herolab)! and! bands! were!excised! from! agarose! gel! using! a! clean,! sharp! scalpel.! DNA!was! cleaned! up! and!purified!from!agarose!gel!using!QIAEX!II!gel!extraction!kit!(Qiagen)!following!the!manufacturer's!protocol.!
2.1.4!RESTRICTION!ENZYME!DIGEST!1S5µg!of!DNA!were!cut!in!reaction!volume!of!10S50µl!per!µg!of!DNA.!Restriction!digests!were!prepared!on!ice!and!components!added!to!a!sterile!0.6!ml!microtube.!The! DNA!was! digested! following! the!manufacturer's! protocol! using! 1S5! units! of!restriction! enzyme! (Promega)! and! the! appropriate! 10x! buffer! (Promega).! The!enzyme!was! then!heat! inactivated!at!65oC! for!15!minutes.!For!double! restriction!digests,! an! initial! digest! was! performed,! heat! activated! and! cleaned! up! from!solution! using! the! QIAEX! II! S! gel! extraction! kit! (Qiagen)! (See! section! 2.1.3.).!Subsequently! the! second! digest! was! performed! and! then! heat! inactivated.!Restriction! digest! product! was! run! on! an! agarose! gel! (see! section! 2.1.2)! for!analysis!and!extraction!(see!section!2.1.3).!!
2.1.5!DNA!LIGATION!Ligation!of!DNA!insert!into!a!restriction!digested!plasmid!vector!was!performed!in! a! 10µl! reaction! (see! table! 2.2)! using! T4! DNA! ligase! (Promega)! and! the!appropriate!10x!ligase!buffer!(Promega),!following!the!manufacturers!protocol.!
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2.1.6!FORMATION!OF!CaCl2SCOMPETENT!DH5α!CELLS!Competent!Escherichia.Coli! (E.Coli)!DH5α!cells!were!generated! from!a!glycerol!scrape!of!E.Coli!DH5α!which!was!grown!in!5ml!Luria!Bertani!(LB)!medium!(Sigma).!The!bacterial!cells!were!incubated!for!16S18!hours!rocking!at!210rpm,!37oC!in!an!orbital! incubator.!After! incubation!0.5ml!of! the!DH5α!culture!was!then!diluted! in!50ml!of!LB!medium!and!rocked!at!210rpm!until!an!absorbance!of!0.3S0.4!was!read!at! 600nm! (Uv! Spectrophotometer,! Shimadzu).! DH5α! cells! were! harvested! by!centrifugation,!3500xg!for!10!minutes!at!4oC!using!a!4.2!rotar!Beckman!Coulter!J6SMI! (Beckman).! The! cells! were! placed! on! ice,! the! supernatant! was! carefully!removed! and! the! cell! pellet!was! gently! resuspended! in! 20ml! of! iceScold! 100mM!calcium! chloride! (CaCl2).! The! cells! were! then! incubated! on! ice! for! 30! minutes,!following! this! the! cells! were! centrifuged! at! 1000xg.! Supernatant! was! again!removed!gently! and! the! cell! pellet!was! resuspended! in!1ml!of!100mM!CaCl2! and!incubated!on!ice!for!a!further!30!minutes!before!transformation!(see!section!2.1.7).!For!future!use,!aliquots!of!DH5α!cells!were!stored!at!S80!in!20%!glycerol.!!!!
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2.1.7!TRANSFORMATION!To! a! 200µl! aliquot! of! competent! DH5α! cells! in! a! 1.5ml! microtube,! 10! µl! of!ligation!product! (see!2.1.5)!was!added!and! incubated!on! ice! for!30!minutes.!The!bacterial!cells!plus!ligation!product!was!then!heat!shocked!at!42oC!for!45!seconds!and!placed!on!ice!for!a!further!minute.!800!µl!of!SOC!medium!(2%!tryptone,!0.5%!yeast!extract,!NaCl!10mM,!MgCl2!2mM,!MgSO4!10mM,!2.5mM!KCl,!glucose!20mM!)!was!added!to!the!transformation!mix!which!was!then!incubated!at!37oC!in!a!preSwarmed! orbital! incubator! at! 210rpm! for! 45S60! minutes.! LBSAgar! plates! were!prepared! with! the! appropriate! antibiotic! resistance! for! the! DNA! plasmid! (100!µg/ml!ampicillin!or!50!µg/ml!kanamycin).!100!µl!of!the!incubated!transformation!culture! was! spread! onto! the! relevant! agar! plates! and! incubated! at! 37oC! upside!down! for! 16S18! hours.! When! ligating! into! a! pGEMT! easy! plasmids,! DH5α!transformed! cells! were! spread! on! to! LB/ampicillin/IPTG/XSGal! plates! (LBSagar,!100!µg/ml!ampicillin,!0.1mM!IPTG!and!2%!XSGal).!





2.2.1!CELL!CULTURE!All! cells!were!cultured! in!Nunc!TS75!or!TS25!plastic! flasks,!at!37oC! in!a!humid!incubator! in! the! presence! of! 5%! CO2.! Human! embryonic! kidney! 293! (HEK! 293)!cells!were!cultured!in!minimum!essential!medium!eagle!(MEM)!(Invitrogen)!with!added! 10%! foetal! calf! serum! (FCS)! (Seralab),! 100! units! Penicillin! 0.1mg/ml!Streptomycin,! and! 2mM! LSGlutamine.! Human! neuroblstoma! cell! lines! (SKSNSSH)!were! cultured! in! Dulbecco's! Modified! Eagle’s! Medium! (DMEM)! with! additional!10%! FCS,! 100! units! Penicillin! 0.1mg/ml! Streptomycin,! and! 2mM! LSGlutamine!(P/S/G).!
2.2.2!PASSAGE!OF!CELLS!All!cells!were!passaged!when!reached!a!70S80%!confluent! layer! in! the!culture!dish.!When!confluent,!culture!medium!was!aspirated!and!cells!were!washed!with!preSwarmed! (37oC)! 1! x! phosphate! buffered! saline! (PBS).! Cells! were! then!trypsinised!from!the!culture!dish!by!adding!0.05%!trypsin/!0.02%!EDTA!solution!(Sigma),!either!500µl!(T25!flask)!or!up!to!3ml!(T75!flask),!and!incubated!at!37oC,!5%!CO2!for!1S5!minutes!depending!on!adherence!of!cells.!Once!cells!are!detached!from!culture!dish,!they!are!taken!up!in!5S10!ml!of!fresh!medium!and!transferred!to!a!15ml!tube.!Cells!were!then!pelleted!in!a!centrifuge!for!5!minutes!at!1000xg!and!resuspended!in!fresh!medium.!Cells!were!then!plated!out!into!an!appropriate!dish.!
2.2.3!DNA!TRANSFECTION!OF!MAMMALIAN!CELL!LINES!WITH!LIPOFECTAMINE!2000!TRANSFECTION!REAGENT!! !SKSNSSH! cells! and!were! 90S95%! confluent!within! the! culture! dish!when! they!were! transfected!with! Lipofectamine!2000! reagent! (Invitrogen)! according! to! the!manufacturer’s! protocol! (volumes! for! transfection! see! table! 2.3).! SKSNSSH! cells!were!plated!one!day!before!transfection!either!with!glass!coverslips!or!not.!Cells!on!coverslips! were! used! for! fluorescence! microscopy! and! FRET! whereas! cells!
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35mm! 2.5/5! ½! 500! 2!
T%25!flask! 10! 4! 500! 8!!!











96!well!plate! 0.15! 0.05! 5! 0.1!
35mm! 3/6! 1/2!! 100! 2!
T%25!flask! 9! 2! 150! 8!!!
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2.2.5!STORAGE!OF!CELL!LINES!Cells!are!stored!long!term!in!liquid!nitrogen.!Cells!for!storage!were!trypsinised!(see!section!2.2.2)!and!pelleted!in!a!centrifuge!for!5!minutes!at!1000xg.!Cell!pellet!was!resuspended!in!900µl!of!fresh!cold!medium!and!cooled!down!on!ice.!900µl!of!medium!containing!20%!Dimethyl!sulfoxide!(DMSO)!was!added!to!the!preScooled!cell/medium!mix!to!a!total!volume!of!1.8ml!and!transferred!to!a!Cryotube!(Nunc).!Cryotubes! were! placed! in! an! isopropanol! container! and! cooled! to! S80oC! before!placing!in!liquid!nitrogen.!
2.2.6!RESCUE!OF!FROZEN!CELL!LINES!Cells! were! rescued! from! liquid! nitrogen! stores! by! quickly! thawing! and!transferred! to! culture! dish! containing! appropriate! medium.! The! medium! was!changed!after!24!hours!to!remove!any!residual!DMSO.!
2.3!CELL!ASSAYS!AND!TECHNIQUES!
2.3.1!FIXING!CELLS!35mm!plastic!dishes!(Nunc)!with!glass!coverslips!were!used!to!culture!cell!lines!for!fixing.!After!48!hours!of!transfection!medium!was!aspirated!from!culture!dishes!and! the! cells! were! washed! very! gently! with! 1xPBS,! three! times! at! 5! minute!intervals.!Once!washed!cells!were!fixed!with!4%!paraformaldehyde!(PFA)!and!left!for!20!minutes!at!room!temperature!in!the!dark.!Remaining!4%!PFA!was!removed!after! 20! minutes! and! the! cells! were! again! washed! with! 1xPBS,! four! times! at! 5!minute!intervals.!The!coverslips!were!then!mounted!onto!glass!slides!using!mowiol!(Sigma)!with!or!without!4',6SdiamidinoS2Sphenylindole!(DAPI).!Slides!were!imaged!using!multiphoton!confocal!laser!scanning!microscope!(Leica).!!!!!!!
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2.3.2!MITOTRACKER!STAINING!Cells!were!cultured!(see!sections!2.2.1!S!2.2.4)!in!35mm!dishes!(Nunc)!on!glass!slides.!MitoTracker!Deep!red!probe!was!used!to!selectively!dye!the!mitochondria.!The!MitoTracker!was! diluted! to! a! concentration! of! 100nM! (for! cell! lines)! in! the!appropriate! medium;! medium! from! the! cell! culture! dish! was! aspirated! and!replaced!with!1S2ml!of!the!diluted!MitoTracker.!The!cells!were!then!incubated!for!20S40!minutes!at!37oC,!5%!CO2.!After! incubation!with! the!mitochondrial!dye,! the!cells! were! washed! with! preSwarmed! medium! and! then! fixed! for! imaging! (see!2.3.1).!MitoTracker! staining!was!visualized!by! excitation!at!633nm!and!emission!collected! at! 640S670nm!using! a!multiphoton! confocal! laser! scanning!microscope!(Leica).!!




2.3.4!ABAD!ENZYME!ACTIVITY!ASSAY!2.3.4.1!CELL!CULTURE!HEK!293!and!SKSNSSH!cells!were!cultured!in!a!black!walled!clear!bottom!96!well!plates! (Thermo' Scientific' Nunc)' and! HEK! 293! cells! were! transfected! after! 24!hours!whereas!SKSNSSH!cells!were!not!transfected!(see!section!2.2.4).!!!2.3.4.2!GLUCOSE!DEPLETION!48! hours! after! plating,! cell! medium! was! substituted,! for! a! phenol! red! free!medium!supplemented!with!altered!glucose!concentrations!(see!table!2.5).!!HEK! 293! medium:! Low! glucose! (1g/l),! phenol! red! free! and! no! glutamine! MEM!(Invitrogen):! 1%!FCS! (charcoal! filtered),! Penicillin! 0.1mg/ml! Streptomycin! (P/S)!and!10mM!HEPES.!SKSNSSH!medium:!No! glucose,! phenol! red! free! and! no! glutamine!DMEM!powder!(Sigma)!(made!up!according!to!the!manufacturer’s!instructions):!1%!FCS!(charcoal!filtered),!Penicillin!0.1mg/ml!Streptomycin!(P/S)!and!10mM!HEPES.!








2.3.4.3!FLUORESCENT!MEASURMENT!ASSAY!24!hours!after!the!glucose!concentration!has!been!reduced!in!the!medium,!it!is!removed!and!replaced!with!glucose!depleted,!phenol!red!free!medium!containing!20µM!of! the! fluorogenic! probe,! (S)S! CHANA.! The! black!walled! 96!well! plates! are!then!analysed!in!a!96!well!plate!reader!(FLUOstar!Optima!microplate!reader)!for!8!hours!(see!table!2.6).!!Further!analysis!of!fluorescent!measurements!included!calculating!average!and!standard!error!of!the!fluorescent!signal!and!rate!of!CHANK!production!per!minute!with!an!unpaired!TSTest!as!the!statistical!analyisis.!













2.4.1!FLUORESCENCE!RESONANCE!ENERGY!TRANSFER!(FRET)!ANALYSIS!!To!detect!a!proteinSprotein!interaction,!FRET!analysis!can!be!used.!FRET!is!the!energy! transfer! between! fluorphores! with! overlapping! spectra! when! they! are!within! a! 1S10nm! range! of! each! other.! In! this! study! initial! FRET! analysis! was!conducted!on!fixed!cells!and!latterly!on!live!cells.!!2.4.2!FIXED!CELL!FRET!EXPERIMENTS!HEK!293!cells! and!SKSNSSH!cells!were! cultured! in!35mm!dishes!on! coverslips!and! transfected! following! the! protocol! outlined! in! sections! 2.2.4! &! 2.2.3!respectively.!The!cells!were!transfected!with!DNA!plasmids!containing!expression!for!the!proteins!of!interest!and!corresponding!fluorophores!(ECFPSenhanced!cyan!fluorescent!protein!or!EYFPS!enhanced!yellow!fluorescent!protein).!!48!hours!after!transfection! the! cells!were! immobilized!on! the! coverslips! (see! section!2.3.1)! and!mounted! onto! glass! slides! with! mowiol,! these! slides! were! then! imaged! using! a!Leica! TCS! multiphoton! confocal! laser! scanning! microscope.! Subsequently! the!fluorophores!ECFP!and!EYFP!were!excited!with!argon!laser!set!at!458nm!or!514nm!respectively! and!emission!was! collected!between!468S498nm! for!ECFP!and!550S582!nm!for!EYFP.!!To! detect! the! occurrence! of! FRET,! Leica! software! for! the! analysis! of!photobleaching!was!used.!Specific!regions!of!interest!(ROI)!were!highlighted!using!the!software!and!the! following!steps!of!photobleaching!were!conducted.! Initially,!emission! images! of! the! donor! fluorophore! (ECFP)! and! acceptor! fluorophore!(EYFP)!were!captured!before!photobleaching!excited!at!458nm!(laser!power!set!at!55%! of! total! power)! and! 514nm! (laser! power! set! at! 21%! of! total! power)!respectively.! The! next! step! is! the! photobleaching! of! the! acceptor! fluorophore,!which!consists!of!repeated!excitation!at!514nm!laser!at!full!power.!Finally,!images!were!taken!of!the!fluorophores!post!bleaching!and!the!fluorescent!intensities!from!these! images! (Dpost! –! donor! post! bleaching;! Dpre! –! Donor! pre! bleaching)!were!
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2.5.1!WESTERN!BLOTTING!2.5.1.1!BRADFORD!REAGENT!Protein! quantification!was! carried! out! by! using! Bradford! reagent.! A! standard!calibration! curve!was! formed!using! known! concentrations! of!BSA!protein,! 500µl!distilled!H2O!and!500µl!Bradford!reagent.!Form!this!curve!protein!samples!could!be! determined:! 5µl! sample,! 495µl! distilled! H2O! and! 500µl! Bradford! reagent.!Absorbance!was!measured!at!595nm!with!MRX!plate!reader!(DYNEX!Technology).!2.5.1.2!CELL!LYSATES!FOR!SODIUM!DODECYL!SULPHATE–POLYACRYLAMIDE!GEL!ELECTROPHORESIS!(SDSSPAGE)!Cells! were! cultured! and! transfected! (see! sections! 2.2.1! S! 2.2.4)! and! the! cell!lysates! were! harvested! after! 48! hours! of! transfection.! Cell! culture! dishes! were!placed!on!ice,!the!medium!was!aspirated!off!and!the!cells!were!washed!twice!with!iceScold! 1xPBS.! Cells! were! harvested! using! 3S[(3Scholamidopropyl)!dimethylammonio]S1Spropanesulfonate! (CHAPS)! lysis! buffer:! 8.27M! Urea,! 4.7%!(w/v)!CHAPS,!1%!(w/v)!DTT,!1mM!PMSF!and!1%!protease!inhibitor!complex!mix!(Roche).!Cell!lysates!were!collected!and!sonicated!for!30!seconds!and!placed!on!ice!for!15minutes.!They!were! then!spun!at!13,000xg! for!5minutes!at!4oC,!aliquots!of!the!supernatant!were!made!either!stored!at!S20oC!or!used!straight!away!for!SDSSPAGE.!!Samples!for!SDSSPAGE!were!prepared!by!adding!4!x!protein!sample!buffer!(PSB):! 106mM! TrisSHCL,! 141mM! TrisSBase,! 8%! SDS,! 51mM! EDTA,! 40%! (w/v)!glycerol,! 400mM! DTT! and! 0.08%! Bromphenol! Blue.! Once! 4! x! PSB! was! added,!samples! were! heated! to! 100oC! for! 5! minutes,! followed! by! centrifugation! at!13000xg)for!30S60!seconds.!!!!!
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3.1.1!ABAD!INTERACTS!WITH!CYPD!!ABAD! has! been! reported! to! have! protective! functions! within! neurons,! in!particular! the! catalytic! ability! of! ABAD! allows! for! the! attenuation! of! the!accumulations! of! toxic! aldehydes! within! neurons! (Murakami! et! al.,! 2009).! I!propose!that!ABAD!interacts!with!CypD!in!order!to!induce!further!protective!roles!within! the! cell! by! preventing! the! formation! of! the! mPTP! and! consequently! cell!death.!!Evidence!to!suggest!that!ABAD!interacts!with!CypD!originates!from!unpublished!results!in!two!different!studies.!Initially!Yan!and!Stern!(2005)!observed!binding!of!ABAD!to!CypD!and!it!was!suggested!that!this!binding!could!be!either!a!measure!for!maintaining!homeostasis!or!a!protective!mechanism!in!response!to!stress!(Yan!and!Stern,!2005).!!ABAD!binding!to!CypD!could!prevent!the!translocation!of!CypD!to!the!IMM!seen!in!response!to!oxidative!stress!(Connern!and!Halestrap,!1994).!Implying!that!sequestration!of!CypD!by!ABAD!would!therefore!prevent!the!formation!of!the!mPTP!and!furthermore!reduce!mitochondrial!dysfunction!and!cell!death.!!CypD! and! ABAD! have! both! been! established! as! mitochondrial! proteins! and!further! unpublished! observations!witness! the! coSlocalization! of! CypD! and! ABAD!(Ren,!2008).!!Following!these!results,!acceptor!photoSbleaching!FRET!analysis!was!carried!out!with! fluorescently! tagged!ABAD!and!CypD!proteins.!Strongly!positive!FRET!signals!were!noted!an!thus!signifying!an!interaction!between!these!proteins!(Ren,!2008).!To! further! investigate! the! possible! binding! of! ABAD! with! CypD! in! the!mitochondria!three!different!methods!were!used;!acceptor!photoSbleaching!FRET!analysis! on! immobilised! cells,! spectroscopic! FRET! analysis! with! live! cells! and!immunoprecipitation.!!
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3.1.2!FRET!ANALYSIS!!The! process! of! FRET! is! used! to! detect! proteinSprotein! interactions! by! the!distances! between! fluorophores! tagged! to! the! proteins! of! interest.! Different!fluorophores!with! overSlapping! excitation! and! emission!wavelengths! are!used! in!order!to!observe!FRET!interactions.!The!overSlapping!spectrum!is!crucial!as!when!the! fluorophore! tags! are! within! a! 1S10nm! range! of! each! other! and! the! donor!fluorphore!has!been!excited,!the!emission!from!the!donor!will!excite!the!acceptor!fluorophore! (Wallrabe! and! Periasamy,! 2005).! Only! when! the! fluorophores! are!within!this!specific!range!will!FRET!occur,!this!is!important!as!proteins!will!only!be!close!enough!to!cause!FRET!if!they!are!interacting!with!each!other.!!!Confocal!microscopy!is!primarily!used!to!record!FRET!however!other!methods!that! can! be! used! include! spectral! imaging! using! a! spectrophotometer,! which!measures! the! fluorescent! emission! spectra.! The! intensity! of! emission! spectra! is!then!used!to!determine!the!intensity!of!FRET!(Clegg,!1992).!Measuring! FRET! with! a! confocal! microscope! can! either! be! done! by! acceptor!photoSbleaching,! sensitised! emission! or! via! fluorescence! lifetime! imaging!microscopy!(FLIM).!! FLIMSFRET!!The!principle!of!FLIMSFRET! is!based!on! the! lifetime!of! fluorophores.!Standard!FLIM! measures! the! rate! of! decay! of! fluorescence! emission,! which! is! altered! by!changes! in!pH,! ions!and! importantly!FRET!(Wallrabe!and!Periasamy,!2005).!This!technique! can! therefore! be! used! to! investigate! proteinSprotein! interactions! by!measuring!the!increase!in!the!decay!of!emission.!Initially!the!lifetime!of!the!donor!fluorophore! must! be! measured! along! with! the! lifeStime! of! the! donor! when! the!acceptor!fluorophore!is!present!to!allow!for!FRET!efficiency!to!be!calculated.!!!!!
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SENSITISED!EMISSION!!Sensitised! emission! of! the! acceptor! fluorophore! is! a! simple! method! using! a!confocal!microscope.!The!donor!fluorophore!is!excited!and!due!to!the!overlapping!fluorescence! spectra,! the! emission! from! the! donor! should! excite! the! acceptor! if!they!are!within!the!10nm!range.!Therefore,!to!analyse!the!occurrence!of!FRET,!only!the! emission! from! the! acceptor! fluorophore! is! recorded.! However,! sensitised!emission! is! prone! to! inaccuracies! due! to! the! neighbouring! fluorescence! spectras!and!must! have! strict! controls! in! order! to! reduce! spectral! bleedSthrough! (crossStalk)!emission.!Spectral!bleedSthrough!can!occur!as!a!consequence!of!the!excitation!of! the!donor!wavelength!exciting! the!acceptor!and! so!a! control!where! the!donor!fluorophore! is! absent! is! essential! to! allow! for! reduction! of! the! background!fluorescence!in!this!method!of!FRET!(Wallrabe!and!Periasamy,!2005).!ACCEPTOR!PHOTOSBLEACHING!The! method! behind! acceptor! photoSbleaching! is! based! on! the! repeated!excitation! of! the! acceptor! fluorophore! which! prevents! excitation! by! the! donor!fluorophore! (Swift,! 2004).! In! this! instance! FRET! is! measured! by! the! increased!fluorescence!intensity!emitted!by!the!donor!fluorophore!caused!by!the!inability!to!excite! the! bleached! acceptor! by! ‘donating’! its! fluorescence.! This! method! for!analysing! FRET! removes! the! likelihood! of! spectral! bleedSthrough! due! to! the!removal! of! one! fluorophore.! Acceptor! photoSbleaching! is! ideal! for! fixed! cell!imaging!as!fully!photoSbleaching!live!cell!is!problematic!due!to!cellular!movement,!morphology!and!focal!plane,!these!problems!also!occur!in!time!lapse!experiments!(Zal! and! Gascoigne,! 2004).! Acceptor! photoSbleaching! was! the! method! of! FRET!initially! used! to! discover! the! positive! interaction! between! ABAD! and! CypD! and!therefore!this!method!was!attempted!in!order!to!replicate!the!study.!!FRET!was!determined!by!tagging!the!two!proteins!with!fluorophore!pairs,!ABAD!was! tagged! with! the! acceptor! fluorophore! EYFP! (enhanced! yellow! fluorescent!protein)!and!CypD!was! tagged!with! the!donor! fluorophore!ECFP!(enhanced!cyan!fluorescent!protein).!Both!of! these! fluorescent!spectra!overlap!allowing! for!FRET!to! occur! (Figure! 3.1).! Excitation! wavelength! for! the! donor,! CFP,! has! two! major!
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excitation!peaks!at!434nm!and!453nm!whereas!the!excitation!of!the!acceptor,!YFP,!ranges! between! 450–565nm! and! only! has! one!major! excitation! peak! at! 514nm.!!Emission! from! CFP! spans! between! 460–520nm!with!main! peaks! at! 475nm! and!501nm!therefore!allowing!excitation!of!YFP.!!!!!!!!!!




These!three!measurements!allow!for!the!calculation!of!the!ratio!A!value.!Ratio!A!is!proportional! to! the! FRET! efficiency! and! signifies! the! intensity! of! the! FRET!interaction!(Clegg,!1992).!!!!To!calculate!ratio!A!the!intensity!emitted!from!step!A!and!B!must!be!normalised!at!peak!488nm!(the!emission!peak!observed!for!ECFP),!this!permits!the!subtraction!of! the! pure! donor! intensity! from! the! experimental! donor! intensity! (B%A).! The!remaining!fluorescence!intensity!therefore!is!a!consequence!of!FRET!whereby,!the!donor!emission!has!excited!the!acceptor!to!emit!fluorescence!and!therefore!this!is!a! good! indicator! of! FRET.! Furthermore,! to! gain! Ratio! A,! the! remaining! emitted!intensity! from!the!experimental!acceptor!(D)! is!divided!by!the!acceptor!emission!when!excited!at!517nm!(obtaining!the!acceptor!emission!intensity).!This!division!will!give!the!ratio!A!value!and!signify!the!intensity!of!the!FRET!interaction.!!!
3.1.3!IMMUNOPRECIPITATION!!To! further! investigate! the! interaction! between! ABAD! and! CypD!immunoprecipitation!was!used.!The!process!of!immunoprecipitation!uses!specific!antibodies! to! identify! proteins! within! a! sample! of! whole! cell! lysates.!Immunoprecipitation! can! be! used! to! detect! singular! proteins! or! bound! protein!complexes.))!The! principle! behind! immunoprecipitation! originates! from! an!immunoadsorbent!property!possessed!by!protein!A!and!G!found!in!bacterial!walls!of!Staphylococcus)aureus!and!Streptococci!strains!C!and!G,!respectively!(Firestone!and!Winguth,! 1990,! Sjobring! et! al.,! 1991).! Protein!A! and!G! bind! to! the! fragment!crystallizable!(Fc)!regions!of!antibodies,!and!these!proteins!are!used!to!coat!a!solid!state!matrix!such!as!Sepharose!(Separation!Pharmacia!agarose)/agarose!beads.!
Ratio A = Area under (D)/ Area under (E) 
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The! standard! methods! for! immunoprecipitation! are! either! direct! or! indirect.!The! direct! method! uses! coated! agarose! beads! whereby! the! specific! antibody!required!is!coupled!before!the!addition!of!cell!lysates.!The!indirect!method!allows!the!specific!antibody!to!bind!within!the!cell! lysates! first,!and!then!protein!coated!agarose!is!added!to!the!lysates!which!binds!to!the!antibody.!The!indirect!method!of!immunoprecipitation! is!preferentially!used!as! the!antibody! is! able! to!bind! to! the!protein! of! interest! naturally!without! hindrance! from! the! coupled! agarose! beads!(Thompson,!2004).!!In! order! to! detect! if! ABAD! binds! to! CypD,! GFPSTrap! A! binding! proteins!were!used.! GFPSTrap! A! beads! have! a! GFP! binding! protein! (an! antibody)! coupled! to!agarose! which! encompass! a! high! affinity! for! epitopes! on! GFP! and! YFP.! In! this!instance!the!antibody!for!GFP!is!used!to!pull!down!the!EYFPStagged!ABAD!protein!and! it! is!hypothesised! that!an! interaction!between!ABAD!and!CypD!will! result! in!the!presence!of!CypD!in!the!final!pull!down!precipitate.!OverSexpression!of!ABAD!and!CypD!within!cell!lines!increased!the!potential!for!witnessing!an!interaction!between!the!pair.!Using!GFPSTrap!A!beads,!the!EYFP!tag!on!ABAD!was!initially!employed!to!pull!down!the!overexpressed!ECFP!fused!CypD!protein.!However,!CFP!was!found!to!interfere!with!the!immunoprecipitation!and!a!mycStagged! CypD! was! created! in! order! to! counteract! this! interference.!!Additionally,! as! CFP!was! found! to! bind! to! the!GFPSTrap!A! beads! the!ECFPSfused!CypD! was! overexpressed! in! cell! lysates! with! a! mitochondrial! targeted! ABAD!protein.!This!allowed!for!the!prevention!of!any!interference!from!the!large!protein!tags!affecting!the!regions!of!interaction.!!
3.2!AIMS!OF!CHAPTER!In!the!presence!of!Aβ!and!oxidative!stress,!CypD!translocates!from!the!matrix!of!the! mitochondria! to! the! IMM! where! it! associates! with! the! ANT! and! the! VDAC!forming! the!mPTP! across! the! IMM! and! the! OMM! (Singh! et! al.,! 2009).! This! pore!facilitates!mitochondrial!dysfunction!and! cell! death,! the! translocation!of!CypD! to!
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the!IMM!and!the!presence!of!Aβ!are!the!triggers!for!these!consequences,!Aβ!could!be!the!disruptive!factor!behind!the!translocation!of!CypD.!!Considering! that! Aβ! has! been! shown! to! bind! to! ABAD! and! prevent! enzyme!functioning,! this! interaction! could! also! cause! a! disruption!of! potential! protective!activity!of!ABAD!whereby!ABAD!sequesters!CypD!away!from!the!IMM.!The!ability!of!ABAD!to!retain!CypD!away!from!the!IMM!would!reduce!the!likelihood!of!mPTP!formation!and!consequently!prevent!cell!death.!In! order! to! ascertain! if! ABAD! binds! to! CypD! three! methods! used! to! detect!proteinSprotein! interactions! were! used,! acceptor! photoSbleaching! FRET,!spectroscopic!FRET!analysis!!and!immunoprecipitation.!!!!
3.3!RESULTS:!FӦRSTER!RESONANCE!ENERGY!TRANSFER!ANALYSIS!OF!THE!ABAD!–CypD!INTERACTION!!To! determine! a! FRET! interaction! between! CypD! and! ABAD,! both! proteins!needed! to! be! tagged! with! pairing! fluorophores.! A! plasmid! containing! a!mitochondrial!targeting!sequence,!ABAD!and!a!EYFP!(pMTSSABADSEYFP)!had!been!previously!produced!in!our!laboratory!by!Dr!Yimin!Ren!and!a!plasmid!with!CypD!and! ECFP! (pCypDSECFP)! was! gifted! to! us! by! Dr! Anne! Murphy! (Department! of!Pharmacology,!University!of!California,!San!Diego).!!!
3.3.1!COSLOCALISATION!OF!MTSSABADSEYFP!AND!CYPDSECFP!To! confirm! the! coSlocalization! of!MTSSABADSEYFP! and! CypDSECFP!within! the!mitochondria,!HEK!293!cells!were!grown!on!glass!coverslips!in!35mm!dishes!and!transfected!with!either!both!plasmids!or!on!their!own.!Cells!were!immobilised!on!the!coverslips!with!4%!PFA!(as!in!section!2.3.1)!and!mounted!to!glass!slides!with!Mowiol+Dapi! solution! (Cells! transfected! with! pCypDSECFP! were! mounted! with!Mowiol!without!Dapi).!MitoTracker!was!used!to!verify!mitochondrial! localisation!
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Figure!3S2:!A)HEK!293! cells! expressing!MTSSABADSEYFP(yellow)! in! the!mitochondria!and! B)! HEK! 293! cells! expressing! CypDSECFP(light! blue)! appearing! in! the! nucleus.C)!overlapping! image! of! A! and! B.! D)! HEK! 293! cells! expressing! MTSSABADSEYFP,! E)!stained!with!Dapi!(dark!blue)and!F)!MitoTracker!deep!red!(red).!G)!Overlapping!image!of!DSF.!
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3.3.2!CONSTRUCTION!OF!pMTSSCypDSECFP!!To! create! a! mitochondrialSdirected! pMTSSCypDSECFP! plasmid,! the! DNA!sequence! for! CypDSECFP! was! ligated! into! pDsRed2SMito! plasmid! (Clontech),!therefore! using! the!mitochondrial! targeting! sequence! from! this! plasmid,! cloning!strategy! is! outlined! in! figure! 3.3.! The! mitochondrial! targeting! sequence! is! from!subunit! VIII! of! human! COX! and! has! been! expressed! in! a!mammalian! expression!vector!along!with!red!fluorescent!protein!isolated!from!Discosoma)sp!(Matz!et!al.,!1999,!Clontech,!2003).!! Initially,! a! restriction! digest! of! the! target! plasmid! the! pDsRed2SMito! using!





Figure! 3.3:! One! step! cloning! strategy:! pDsRed2.mito!was! digested!with!BamHI!and! NotI! to! allow! for! insertion! of! the! PCR! fragment.! PCR! was! conducted!following! protocol! outlined! in! section! 2.1.1! with! annealing! temperature! at!61.9oC! using! 100ng! of! the! template! DNA,! pCypD.ECFP.! The! PCR! fragment!containing!CypD.ECFP!was!ligated!into!the!digested!DsRed2.mito!DNA!plasmid.!!
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respectively.!The!same!approach!was!applied!when!transfecting!cells!with!control!DNA.! There! were! two! negative! controls:! HEK! 293! cells! transfected! with! pMTS*CypD*ECFP!alone!and!HEK!293!cells!transfected!with!pMTS*CypD*ECFP!and!pEYFP!plasmid!(Clontech).!The!positive!control!was!a!fusion!protein!given!as!a!gift!from!Professor! J.!Tavaré!(Department of Biochemistry, University of Bristol).!This! fusion!protein! expressing! ECFP! and! EYFP! is! connected! by! the! 18! amino! acid! sequence!from!the!caspase!3!cleavage!site!DEVD!(pECFP*DEVD*EYFP)!(Tyas!et!al.,!2000).!!
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Previous! FRET! analysis! of! the! pECFP*DEVD*EYFP! construct! expressed! in! COS*7!cells! has! shown! that! in! the! presence! of! caspase! 3,! FRET! is! disturbed! as! the!fluorophores!are!cleaved!apart,!therefore!the!distance!between!the!fluorophores!is!such!that!FRET!will!occur!under!normal!cellular!activity!(Brophy!et!al.,!2002).!!!Initially,! HEK! 293! and! SK*N*SH! cells! were! seeded! onto! coverslips! in! 35mm!dishes!and!once!confluent,!transfected!with!varying!plasmid!DNA!(see!section!2.2).!After! 48! hours! cells!were! immobilised! on! the! coverslips! and! fixed!with! 4%!PFA!onto!glass!slides!(see!section!2.3.1).!The!glass!slides!were!imaged!using!a!Leica!TCS!multiphoton! confocal! laser! scanning!microscope!with! argon! lasers! set! at! 458nm!and!514nm!which!excite!ECFP!and!EYFP!respectively.! !For!the!excitation!of!ECFP!the! 458nm! laser! intensity! was! set! at! 55%! and! emission! was! collected! between!468*498nm.! EYFP! was! excited! at! 514nm! and! emission! collected! between! 550*582nm,!laser!intensity!of!the!514nm!laser!was!set!at!21%!of!total!power.!!To! verify! the! presence! of! FRET! using! acceptor! photo*bleaching! the! positive!control! was! examined! first.! After! several! attempts! no! FRET! was! observed.!!Suggestions!for!why!this!occurred!may!be!derived!from!the!immobilisation!of!the!cells,!as!the!fluorophores!may!not!be!able!to!interact!if!they!were!not!in!the!correct!orientation.! Furthermore,! the! reliability! of! other! FRET! interactions! that! could!occur! is! reduced! due! to! immobilising! the! cells.! Previously! studies! using! this!construct! have! been! carried! out! in! live! cell! experiments! and! after! personal!communication! with! Professor! Tavaré! it! was! recommended! that! FRET!investigations!using!this!construct!would!be!best!conducted!with!live!cells.!!Following! this! advice! further! FRET! investigations! were! carried! out! by!measuring! the! emission! spectra! of! the! fluorophores! using! a! spectrophotometer!and! calculating! the! ratio!A!value.!Ratio!A! is! the!difference!between! the! emission!produced!from!the!acceptor!when!the!donor!is!excited!over!the!emission!produced!when! the! acceptor! is! excited! (Clegg,! 1992).! This! ratio! can! signify! if! FRET! is!occurring! by! comparing! the! emission! spectra! given! off! from! the! acceptor!fluorophore.!!
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3.3.4!INVESTIGATION!OF!THE!ABAD*CypD!INTERACTION!BY!SPECTROSCOPIC!FRET!ANALYSIS!!FRET! interactions! between! MTS*ABAD*EYFP! and! MTS*CypD*ECFP! can! be!deduced! by! measuring! their! fluorescent! spectra! under! differing! conditions.!Examining!live!cells!for!a!FRET!interaction!is!a!much!more!robust!method!as!cells!reside! in! a! physiologically! similar! environment! allowing! clearer! detection! of!potential!protein*protein!interactions.!!HEK!293!and!SK*N*SH!cells!were!grown! in!35mm!dishes!and!transfected!with!plasmids! expressing! a! combination! of! the! following! proteins:! pMTS*CypD*ECFP,!pMTS*ABAD*EYFP,! pEYFP*DEVD*ECFP,! pEYFP! (see! sections! 2.2.1,! 2.2.3,! 2.2.4,!2.4.3).!After!48!hours!the!cells!were!collected,!resuspended!in!1xPBS!and!held!on!ice.!The!first!measurement!taken!was!from!the!cells!transfected!with!pMTS*CypD*ECFP,! the! pure! donor! fluorophore.! The! cell! suspension! was! added! to! a! quartz!cuvette! and! excited! with! the! laser! line! at! 436nm,! the! fluorescent! emission!spectrum! recorded! from! the! pure! donor! (A)! was! used! to! calculate! the!experimental! emission! from! the! acceptor! fluorophore.! Secondly! the! emission!spectrum!from!the!experimental!condition!was!measured,!here!pMTS*CypD*ECFP!and!pMTS*ABAD*EYFP!were!transfected!together!and!excited!at!436nm,!the!donor!emission! from! the! experimental! condition! (B)! was! also! used! to! calculate! the!emission!from!the!acceptor!when!excited!at!436nm.!Once!the!emission!spectra!for!the!pure!donor!and!the!experimental!donor!were!recorded,!the!intensity!of!the!emissions!spectra!were!normalised!at!488nm!(donor!emission!peak).!The!resulting!normalised!emission!data!was!used!to!determine!the!experimental!acceptor!emission!spectra!by!subtracting!the!spectra!(B*A)!to! leave!the! residing! emission! from! the! acceptor! fluorophore!when! excited! by! the! donor!emission! (D).! Finally! the! cell! suspension! from! the! experimental! condition! was!excited!at!the!acceptor!excitation!wavelength!of!517nm.!The!subsequent!emission!spectra!between!526*700nm!(E)!was!used!to!calculate!ratio!A!(Figure!3.6).!!! Ratio A = Area under (D)/ Area under (E) 
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!!!!!!!!!!!!!!!!!The!spectroscopic!FRET!analysis!of!the!ABAD*CypD!interaction!in!HEK!293!cells!revealed!a!weak!FRET! interaction.!The! ratio!A!value! is!proportional! to! the!FRET!efficiency!and! from! the! results,! shown! in! figure!3.6,! it! can!be!determined! that! in!HEK!293!cells,!ratio!A!for!a!potential!!ABAD*CypD!interaction!is!10%!of!the!ratio!A!observed! in! the! positive! control.! This! is! a! good! indicator! that! FRET! and!consequently!and!interaction!between!ABAD!and!CypD!is!occurring.!!!
A B 




Furthermore,! in! comparison! to!HEK!293!cells,! SK*N*SH!cells!expressing!ABAD!and!CypD,!the!ratio!A!value!is!higher!proportional!to!the!ratio!A!determined!for!the!positive!control,!at!25%.!The!results!from!the!SK*N*SH!cells!further!indicate!a!weak!FRET!interaction.!
3.4!RESULTS:!IMMUNOPRECIPITATION!The!positive!but!weak!FRET! interaction!between!ABAD!and!CypD!observed! in!live! cell! experiments!was! investigated! further!by! immunoprecipitation.!The!pull*down! assay! was! carried! out! to! explore! if! the! interaction! was! strong! enough! to!allow!precipitation! from! solution! of! ABAD!bound! to! CypD.! In! these! experiments!GFP!trap!beads!were!used!to!bind!to!the!EYFP!tag!of!MTS*ABAD*EYFP,!and!it!was!predicted! that!MTS*ABAD*EYFP!would!bind! to!MTS*CypD*ECFP!co*transfected! in!HEK!293!cells.!!In!order!to!ascertain!if!the!large!ECFP!protein!tag!attached!to!CypD!affected! the! hypothesised! ABAD*CypD! interaction,! a! plasmid! expressing! CypD!without!ECFP!but!with!a!myc!tag!was!created.!This!CypD*myc!fusion!protein!was!predicted!to!be!pulled!from!solution!with!ABAD!using!the!EYFP!tag.!!
3.4.1!CONSTRUCTION!OF!pCypD*MYC!




Figure 3-7: one step cloning strategy: pcDNA4/TO/myc-His A vector was digested 



































3.4.2!IMMUNOPRECIPITATION!OF!MTS4ABAD4EYFP!USING!GFP!BINDING!PROTEINS!!HEK! 293! cells! were! seeded! in! 35mm! dishes,! after! 24! hours,! they! were!transfected! (section! 2.2.4)! with! a! combination! of! DNA! plasmid! expressing! the!following!different!proteins:!pMTS4ABAD4EYFP,!pMTS4ABAD! (a!kind!gift! from!Dr!Kirsty! E! A!Muirhead),! pMTS4CypD4ECFP,! pCypD4ECFP,! pEYFP! (Clontech),! pECFP!(Clontech),!pCyp4myc,!pcDNA3.;!of!which!one!plasmid!would!contain!the!required!EYFP,! to! enable! binding! to! the! GFP! binding! protein.! Whole! cell! lysates! were!collected! 48! hours! after! transfection,! following! the!manufacturer’s! protocol! (see!section!2.3.3)! cell! lysates!were! incubated!with!pre4washed!GFP!binding!proteins!and! the! resultant! protein! samples!were! analysed! by! SDS4PAGE! gel! and!western!blot!(see!section!2.5.1).!!Initially,! using! the!GFP!Trap!A,!MTS4ABAD4EYFP!was! seen! to! bind! to! the!GFP!binding!protein,!this!is!shown!in!figure!3.8!in!the!bound!fractions!containing!MTS4ABAD4EYFP!(Figure!3.8).!Western!blot!analysis!with!CypD!antibody!indicates!that!MTS4CypD4ECFP! has! either! been! pulled! down!with!MTS4ABAD4EYFP! or! that! the!ECFP! has! bound! to! the! GFP! binding! protein.! Interestingly! MTS4CypD4ECFP! also!appeared!in!the!bound!fraction!when!only!pEYFP!was!present.!Additionally,!CypD4myc!was!not!seen!to!be!precipitated!with!MTS4ABAD4EYFP.!These!results!suggest!that!the!ECFP!present!binds!to!the!GFP4binding!protein!despite!the!manufacturer’s!claims!that!CFP!cannot!bind!due!to!amino!acid!differences!(Chromotek).!!To!explore!whether!ECFP!could!bind!to!the!GFP!Trap!A!beads!and!potentially!be!used! to! immunoprecipitate! MTS4ABAD,! pMTS4CypD4ECFP! was! transfected! with!pMTS4ABAD.!Investigating!immunoprecipitation!with!differently!tagged!constructs!of!ABAD!and!CypD!reduces!interference!from!the!large!fluorescence!proteins,!myc!or! MTS! with! the! hypothesised! ABAD4CypD! interaction.! HEK! 293! cells! were!transfected!with!a!combination!of!the!aforementioned!DNA!plasmids!and!their!cell!lysates!harvested!immunoprecipitated!with!GFP!Trap!A!and!analysed!by!SDS4PAGE!gel! and!western! blot! (see! sections! 2.2.4,! 2.3.3! and!2.5.1).! From! the!western! blot!
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A)# 1! 2! 3! 4! 5! 6! 7! 8! 9! 10! 11! 12!
pECFP! +! +! +! 2! 2! 2! 2! 2! 2! 2! 2! 2!
pCypD2ECFP! 2! 2! 2! +! +! +! 2! 2! 2! 2! 2! 2!
pMTS2CypD2ECFP! 2! 2! 2! 2! 2! 2! +! +! +! 2! 2! 2!
pMTS2ABAD! 2! 2! 2! 2! 2! 2! 2! 2! 2! +! +! +!










Lane! 4>6:! pCypD2! ECFP! alone.! Lane! 7>9:! pMTS2CypD2ECFP.! Lane! 10>12:! pMTS2ABAD!alone.!There!appears!to!be!slight!non2specific!binding!in!lane!6!at!40kDa.!!!
B)#IP!with!Sepharose!A,!Western!blot!with!anti2CypD.!Lane!1>3:!pEYFP!plasmid!alone.!
Lane!4>6:!pMTS2ABAD2EYFP!alone.!Lane!7>9:!pMTS2CypD2myc.!Lane!10>12:!pCypD2myc!alone.!!There!appears!to!be!further!non2specific!binding!in!the!bound!fraction!of!lane!6,!9!and!12!at!30kDa.!!!!







3.5!DISCUSSION!OF!THE!ABAD4CypD!INTERACTION!!!Neuronal! death! and! mitochondrial! dysfunction! in! AD! originates! from! the!necrosis!and!apoptotic!pathways! leading! from!mitochondria.! In!AD,! the!presence!of!Aβ!in!the!mitochondria!has!been!observed!to!bind!to!a!key!enzyme,!ABAD,!which!is! involved! in! fatty! acid!metabolism! (Powell! et! al.,! 2000,! Lustbader! et! al.,! 2004).!Furthermore,! the! occurrence! of! Aβ! in! the! mitochondria! has! been! reported! to!induce! the! production! of! oxidative! stress! which! in! turn! is! noted! to! initiate! the!translocation!of!CypD!to!the! IMM.!Further! investigations!of! the!action!of!CypD!at!the! IMM! have! noted! the! formation! of! the! mPTP! and! the! subsequent! leaky!mitochondria!and!the!initiation!of!energy!independent!process,!necrosis!(Connern!and! Halestrap,! 1992,! Halestrap! and! Brenner,! 2003,! Nakagawa! et! al.,! 2005).! It!would!not!be!prudent!to!suggest!that!as!a!consequence!of!Aβ’s!presence!within!the!mitochondria,! CypD! would! be! prompted! to! translocate! to! the! IMM! due! to! the!oxidative! stress! caused! by! Aβ.! Additionally,! unpublished! observations! have!implied! that! ABAD!binds! to! CypD,! and! so! from! this! it! can! be! suggested! that! the!presence!of!Aβ!and!its!binding!to!ABAD!could!displace!the!endogenous!binding!of!CypD!to!ABAD!in!the!matrix!of!the!mitochondria!(Yan!and!Stern,!2005).!!However,!the! evidence! obtained! from! the! presented! series! of! experiments! suggests! that!there!is!a!weak,!transient!interaction!between!ABAD!and!CypD!signifying!that!the!initial! hypothesis! that,! ABAD! sequesters,! with! a! strong! interaction,! CypD! in! the!mitochondrial!matrix! preventing! translocation! to! the! IMM,! is! not! as! clear! cut! as!originally!believed.!!The! initial! results! obtained! from!acceptor!photo4bleaching! the! fixed! cells! (see!section!3.3.3),!showed!no!signs!of!FRET!in!comparison!to!previous!studies!where!strong! FRET! signals! were! detected! using! this! method! (Ren,! 2008).! Further!investigation! used! intensity4based! FRET! analysis! to! determine! that! a! brief!interaction!appeared!to!occur!between!MTS4ABAD4EYFP!and!MTS4CypD4ECFP.!The!ratio!A!value!gained! from!both!cell! types! (HEK!293!and!SK4N4SH!cells)! is!a!good!indicator! that! FRET! occurs! between! these! two! proteins.! The! ratio! A! value! was!
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notably!higher!in!SK4N4SH!cells!in!comparison!to!HEK!293!cells!which!may!suggest!that!the!interaction!between!ABAD!and!CypD!is!not!a!global!effect!and!that!it!may!be!required!more!in!neuronal!type!cells.!!ABAD! did! not! appear! to! pull! down! CypD! or! vice! versa! in! the!immunoprecipitation!experiments,! insinuating!that!the!interaction!between!these!proteins!is!not!strong!and!that!the!extraction!of!proteins!from!whole!cells!is!a!non4physiological! action! resulting! in! interference! with! the! interaction! (Voss! et! al.,!2005).! This! theory! could! also! be! applied! to! the! reason!why! FRET!was! not! seen!when!the!cells!were!fixed!on!coverslips,!if!the!interaction!is!weak!and!transient!this!biological!surround!could!be!crucial.!Additionally,!the!ABAD4CypD!interaction!may!occur! in! the! initial! stages! of! cellular! stress! as! a! protective! response!mechanism!whereby! ABAD! sequesters! CypD! to! prevent! translocation! to! the! IMM.! The!accumulation!of!excessive!oxidative!stress!could!still! induce!the!translocation!but!before!this!ABAD!could!slow!the!initiation!of!spontaneous!necrosis.!!The!significance!of!the!finding!that!ABAD!interacts!weakly!with!CypD!indicates!that! the! original! hypothesis! that! CypD! scaffolds! to! ABAD! in! the! mitochondrial!matrix,! is! not! correct! (Yan! and! Stern,! 2005).! Strong! binding! between! these!proteins!may! still! occur! but! only! in! response! to! developing! cellular! stress.! This!could! be! further! investigated! by! attempting! to! stimulate! strong! binding! by!inducing!oxidative!stress!or!increasing!calcium!levels!in!transfected!cell! lines!and!further!monitoring!FRET!intensities.!!CypD!could!however,!play!a!very!different!role!in!the!dynamic!relationship!with!ABAD.! The! principal! function! of! ABAD! is! the! β4oxidation! of! fatty! acids,!which! is!crucial! in! the!production! of! ketones! and! subsequently! the!production! of! reserve!energy,! which! is! especially! required! when! glucose! levels! in! the! brain! start! to!decrease.!The!significant!FRET!intensity!recorded!when!CypD!interacts!with!ABAD!therefore!could!indicate!that!CypD!could!be!involved!in!a!metabolic!process!in!the!mitochondrial!matrix.!The!notion!that!CypD!could!be!interacting!with!ABAD!to!aid!a! step! in! the!metabolic! pathway! or! another! oxidation/reduction! reaction! is! not!implausible!as!the!highly!similar!(83%)!Cyclophilin!protein,!AtCyP2043!present!in!
Chapter(3:(Interaction(between(Amyloid(β(Binding(Alcohol(Dehydrogenase(&(Cyclophilin(D(!
86!!















expression!in!wild!type!mice,!under!ischemic!conditions!(transient!middle!cerebral!occlusion:!reduced!glucose)!and! found!that! there!was!an! increased!expression!of!ABAD!in!those!mice!that!underwent!cerebral!ischemia.!In!addition,!transgenic!mice!that!over4expressed!ABAD!were!protected!from!cerebral!ischaemia!and!had!lower!levels!of!β4hydroxybutyrate.! !These! findings! signify! that!ABAD!protein! levels! are!increased!when!neurons!are!under!stress!and!suggest!a!protective!mechanism!of!ABAD!in!the!absence!of!Aβ!peptide.!!! !Following! on! from! this,! I! investigated! specifically! the! activity! of! ABAD!when!glucose! levels! were! reduced! in! the! presence! of! a! synthetic! alcohol! substrate.!Following! on! from! Yan! et! al.! (2000)! where! levels! of! ABAD! expression! were!investigated!under!cellular!stress!(ischemia),!we!hypothesised!that!the!removal!of!glucose! could! directly! stimulate! an! increase! in! ABAD! activity! in! order! to!compensate!for!the!loss!of!glucose.!I!therefore!investigated!the!potential!changes!in!ABAD! activity! under! differing! glucose! concentrations! in! different! cell! lines.!Furthermore,! from! the! previous! finding! that! CypD! interacts! with! ABAD,! I! also!explored!the!potential!effect!CypD!expression!could!have!on!ABAD!activity.!




indirectly! determining! the! activity! of! ABAD! by! measuring! the! intensity! of! the!fluorescence!emitted.!!!!!!!!
4.2!AIMS!OF!CHAPTER!The!primary!aim!of! this! first!part!of! the!chapter!was! to!explore! the!activity!of!ABAD!when!the!glucose!concentration!was!decreased.!The!specifically!constructed!fluorogenic!probe,!(4)4CHANA,!was!used!to!determine!any!changes!in!ABAD!activity!by!measuring!the!intensity!of!the!emitted!fluorescent!light!from!CHANK.!Additionally,! lipidomic! investigations! were! carried! out! to! investigate! the!potential! changes! in! ! lipid! content! of! cells! expressing!ABAD! to!detect! if!ABAD! is!potentially! using! other! substrates.! In( vitro! conditions! of! AD!were! established! by!expressing!ABAD!and/or!mAPP!separately!and!together!in!cell!lines,!with!the!lipid!extracts! obtained! from! these! cell! lysates! analysed! by! lipid! extraction! and!electronspray!ionisation!mass!spectrophotometry!(ESI4MS).!!!!!









!In!the!initial!experiments,!the!emitted!fluorescence!signal!(at!520nm)!from!the!HEK!293!cells!was!measured!over!a!period!of!8!hours.!Figure!4.3!shows!that!over!this! time!period!there!was!an! initial!difference! in!those!cells!expressing!ABAD!as!compared! to! the! control! cells.! In! those! cells! expressing! ABAD,! the! amount! of!fluorescence!emitted!slowed!with!time,!thus!signifying!that!the!enzyme!activity!of!ABAD! had! reached!maximal! activity! within! the! first! 60!minutes! and/or! the! (4)4CHANA! substrate! was! becoming! limiting.! Consequently,! further! experiments!focussed!on!the!first!60!minutes!of!the!reaction!to!determine!the!activity!of!ABAD.!















Therefore! the! same! experiment! was! performed! as! described! above! but!measured!now!over!a!60!minute!time!period.!The!total!fluorescence!signals!over!60!minutes!are!shown!in!the!appendix!and!the!average!mean!is!shown!in!Figure!4.4.!!The!data!in!figure!4.4!displays!an!initial!significant!difference!between!the!HEK!293!cells! expressing!ABAD! compared! to! the! empty! vector! (PcDNA3)! (confirmed! by! a!twoKway! ANOVA).! More! interestingly! are! the! significant! differences! when!comparing! within! conditions! where! ABAD! was! expressed! i.e.! under! conditions!when! the! glucose! concentration!was! reduced! from! 4.5g/l! to! 1g/l! and! 2g/l! there!was!a!significant!contrast!in!the!amount!of!fluorescence!emitted.!!







To! confirm! that! these! changes! observed! were! not! due! to! changes! in! protein!levels,!a!western!blot!was!conducted!of!cells!treated!under!these!conditions!(Figure!4.5).! Western! blot! analysis! of! the! cell! extracts! collected! from! the! pMTSKABAD!transfected!HEK!293!cells!revealed!no!alterations!in!expression!of!ABAD!when!the!concentrations! of! glucose! were! altered! (Figure! 4.5).! Therefore,! the! increased!fluorescence! signal! emitted! when! the! glucose! concentration! was! decreased! was!due!to!changes!in!ABAD!activity!and!not!protein!levels!of!expression.!!!!!!
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In! order! to! verify! that! the! results! obtained! were! due! to! the! varied! glucose!concentrations!and!not!as!a!result!of! increase!or!decrease! in!cell!numbers!a!MTT!assay!was!carried!out!under! the! same!conditions! (see! section!2.3.5! for!protocol).!!HEK!293!cells!were!cultured!in!the!same!manner!as!if!they!were!to!be!used!in!the!fluorescence! assay,! in! a! 96! well! plate.! They! were! subsequently! transfected! with!either!0.05µg!of!pMTSKABAD!or!pcDNA3,!24!hours!later!the!medium!was!replaced!with!phenolKred!and!glutamine!free!MEM!medium!containing!10mM!HEPES!pH7.4,!1%! FCS! (charcoalKfiltered),! penicillin/streptomycin! and! one! of! the! following!concentrations!of!glucose:!4.5g/l,!3g/l,!2g/l!or!1g/l.!After!a! further!24!hours!MTT!
* * 
Figure! 4K6:! The! mean! rate! of! CHANK! production! over! 60! minutes.! ! Statistical!analysis!shows!that!there!is!a!significant!effect!when!ABAD!is!present!(twoKway!ANOVA,!p<0.001).! ! Analysis! to! determine! significance! when! glucose! levels! are!decreased! in! each! condition! (ABAD! or! PcDNA3)! revealed! that!when! ABAD!was!present!there!was!a! significant! increase! in!the!rate!of!CHANK!production!when!glucose! was! decreased! (oneKway! ANOVA,! post( hoc( Bonferroni’s! multiple!comparison’s! test! F(2,12)=11.4,! p<0.05*).! There! was! no! significance! observed!when!ABAD!was!absent!(PcDNA3!control!vector!present)(oneKway!ANOVA,!post(






reagent! was! added! to! 100! µl! of! the! respective! medium! to! make! a! final!concentration!of!1mg/ml.!The!HEK!293!cells!were! incubated!for!5K6!hours,! the!MTT!removed!and!DMSO!added!to!each!well.!The!absorbance!of!the!cells!was!measured!and!the!results!are!shown! in!Figure!4.7.!The!MTT!assay! indicated! that! the!varying! concentrations!of!glucose! did! not! significantly! affect! the! mitochondrial! ability! to! reduce! MTT! to!formazan,! thus! indicating! that! the! differences! observed! between! altering! the!glucose! concentration! from! 4.5g/l! to! 1g/l! is! a! result! of! decreasing! this! energy!substrate!and!not!due!to!increases!or!decreases!in!general!mitochondrial!activity.!!!!!!!!!!
!





4.3.3!ABAD!ACTIVITY!IN!A!NEUROBLASTOMA!CELL!LINE,!SKKNKSH!CELLS!The! experiments! above! indicated! that! decreasing! the! glucose! concentrations!could! directly! induce! ABAD! activity! without! affecting! its! expression! levels.!Therefore,! to!explore! if! this!effect!also!occurs! in!other!cell! lines!and! in!particular!neuronal!like!cell!lines,!SKKNKSH!cells!were!next!investigated.!!SKKNKSH! cells! are! derived! from! a! neuroblastoma! and! so! have! neuronalKlike!qualities,!and!as!such!they!have!been!extensively!utilised!in!the!investigation!of!AD.!!In!addition,!endogenous!levels!of!ABAD!in!SKKNKSH!cells!are!high,!and!so!there!was!no!need!to!transfect!the!SKKNKSH!cells,!allowing!for!an!enquiry!of!the!direct!effect!of!altering! glucose! concentration! on! endogenous! ABAD! activity! in! this! cellKtype!(Muirhead,!2011).!As!the!greatest!effects!were!seen!when!glucose!was!decreased!to!1g/l!in!these!studies,!I!investigated!the!comparison!between!normal!glucose!levels!and!a!reduction!to!1g/l.!Therefore,!SKKNKSH!cells!were!seeded!in!a!blackKwalled!96!well! plate! and! incubated! for!48!hours! at! a!humidity!of!5%!CO2,!at! 37OC.!After!48!hours,! the! cellular! medium! was! replaced! with! a! base! medium! of! varying!concentrations! of! glucose,! glutamine! and! phenol! red! free! DMEM!with! additional!FCS! (1%,! charcoal! filtered),! penicillin/streptomycin! and! HEPES! (10mM,! pH7.4),!and!either!1!or!4.5g/l,!final!concentrations!of!glucose!was!added!to!the!cells.!After!the!cells!were!incubated!for!a!further!24!hours,!20µM!(K)KCHANA!was!added!to!each!well!and!the!plate!was!placed!in!the!FLUOstar!Optima!microplate!reader!to!enable!analysis!of!the!fluorescence!emitted.!!The!total!fluorescence!emitted!at!520nm!was!initially!examined!to!determine!if!there!were! changes!when! the! glucose! concentration!was!decreased.! A! significant!increase! in! the! total! mean! fluorescence! emitted! (over! the! 60! minutes)! was!observed!when!glucose!concentrations!were!decreased!(1g/l)!in!comparison!to!the!normal!concentrations!of!glucose!(4.5g/l)!(Figure!4.8).!The!significant! increase! in!fluorescence! indicates! that! more! CHANK! had! been! produced! over! this! set! time!period.! Analysis! of! the! rate! of! CHANK! production! under! the! decreased! glucose!concentration! also! indicated! a! significant! increase! in! the! overall! rate! of! CHANK!production!in!comparison!to!the!control!(Figure!4.9).!
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Figure	   4-­‐8:	   Total	   mean	   fluorescence	   emitted	   over	   60	   minutes.	   Fluorescent	  signals	  emitted	  from	  the	  activity	  of	  endogenous	  ABAD	  in	  SK-­‐N-­‐SH	  cells.	  Statistical	  analysis	  using	  a	  dependent	  T-­‐Test	  determined	  a	  significant	  increase	  in	  fluorescent	  emission	   when	   glucose	   concentrations	   were	   reduced.	   (t(12)=-­‐160.9	   p<0.001***	  (one-­‐tailed)	  r=0.7)	  N=13	  






In! order! to! confirm! that! cell! viability! and! mitochondrial! activity! were! not!influencing! the! results,! a! MTT! assay! was! performed! under! the! same! conditions!(Figure! 4.10).! Interestingly,! the! assay! showed! a! slight! but! significant! decrease! in!absorbance! when! glucose! concentrations! were! reduced! to! 1g/l.! The! decrease! in!absorbance! implies! that! the! reduction! in! glucose! in! SKKNKSH! cells! impacts! on!general!mitochondrial!activity,!but!even!with!a!decrease! in!mitochondrial!activity!result,!ABAD!activity!was!significantly!increased.!!!!!!!!!!!!In! summary,! differences! were! observed! when! the! glucose! concentration! was!decreased!in!the!cellular!environment!of!both!HEK!293!cells!expressing!ABAD,!but!also!endogenously!ABAD!expressing!SKKNKSH!cells.!!!!!!!



































































Figure! 4K11:! Outline! of! cloning! steps.! pCypDKmyc! was! digested! with!HindIII! and!





4.3.2.2!FLUOROMETRIC!ASSAY!DETERMINING!THE!METABOLIC!EFFECT!OF!CypD!ON!ABAD!!To! investigate! the!effect!CypD!could!have!on! the!activity!of!ABAD,!HEK!293!cells!were!seeded!in!a!black!walled!96!well!plate!and!after!24!hours!they!were!double!transfected!with:!either!0.025µg!of!pMTSKABAD!and!0.025µg!of!pMTSKCypDKmyc!or!0.025µg! of! pMTSKABAD! and! 0.025µg! of! an! empty! control! vector! (pcDNA3).! The!medium!of!the!HEK!293!cells,!after!a!further!24!hours,!was!changed!for!phenolKred!and! glutamine! free! MEM! medium! (with! added! 10mM! HEPES! pH7.4,! 1%! FCS!(charcoalKfiltered),!penicillin/streptomycin)!containing!4.5g/l!of!glucose.!Following!a!24!hour!incubation!period!20µM!(K)KCHANA!was!added!to!the!cells!and!the!black!walled!plate!was!then!transferred!to!the!microplate!reader.!The! rate! of! CHANK! production! recorded! over! 60! minutes! was! significantly!decreased! in!HEK!293! cells! transfected!with!both!ABAD!and!CypD! (Figure!4.12).!!!Under! normal! glucose! concentrations! this! significant! decrease! of! ABAD! activity,!suggests! that! CypD! could! have! an! effect! on! ABAD! activity! in! normal! cellular!functioning.! ! To! determine! if! the! effects! discovered! were! a! consequence! of! the!expression!of!CypD,!western!blot!analysis!was!conducted!along!with!an!MTT!assay!(Figure! 14! &! 15! respectively).! Western! blot! analysis! determined! that! levels! of!ABAD!expression!in!HEK!293!cells!were!not!altered!when!transfected!with!pMTSKABAD!and!pMTSKCypDKmyc!or!control,!pcDNA3!(Figure!4.13).!In!addition!the!MTT!assay! (Figure!4.14)! revealed! that! there!were!also!no!significant!differences!when!CypD!was!expressed!with!ABAD!in!HEK!293!cells!in!comparison!to!ABAD!expressed!with!a!control!vector!(pcDNA3).!! !!!
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Figure	  4-­‐13:	  Expression	  of	  ABAD	  in	  HEK	  293	  cells.	  HEK	  293	  cells	  were	  transfected	  with	   pMTS-­‐ABAD	   and	   pMTS-­‐CypD-­‐myc	   (+CypD)	   or	   pcDNA3	   (-­‐CypD),	   their	   cell	  lysates	   collected	   and	  used	   for	  western	   blot	   analysis.	   Immunoreactive	   bands	  were	  detected	  with	   anti-­‐ABAD	   (Abcam)	   (mouse,	   1:1000)	   and	   anti-­‐mouse	   HRP	   (Abcam)	  (mouse,	   1:20000).	   Bands	   were	   expressed	   at	   ~24kDa	   (MTS-­‐ABAD)	   and	   ~22kDa	  (endogenous	  ABAD).	  As	  a	   loading	  control	  anti-­‐β-­‐actin	  (mouse,	  1:10000)	  with	  anti-­‐mouse	   HRP	   (mouse	   1:20000)	   were	   used	   to	   detect	   actin,	   revealing	   a	   band	   at	   ~	  40kDa.	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Figure	   4-­‐12:	   The	   mean	   rate	   of	   CHANK	   production	   over	   60	   minutes.	   CHANK	  production	   in	   transfected	   HEK	   293	   cells	   expressing	   ABAD	   and	   CypD	   or	   control,	  pcDNA3.	   Statistical	   analysis	   shows	   a	   significant	   decrease	   in	   the	   rate	   of	   CHANK	  production	  when	  CypD	   is	  present	   (dependent	  T–test,	   t(11)	  =	   -­‐13.582,	  p<0.001***,	  
r=0.9).	  N=12/condition.	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  In	  summary,	  from	  the	  results	  obtained	  from	  expressing	  CypD	  with	  ABAD	  in	  HEK	  293	   cells,	   they	   show	   that	   there	  was	   a	   significant	   decrease	   in	   the	   rate	   of	   CHANK	  production	  in	  the	  presence	  of	  elevated	  levels	  of	  CypD,	  indicating	  that	  levels	  of	  CypD	  expression	  can	  influence	  ABAD	  activity.	  	  	  	  	  	  



































































Therefore,! in! this! part! of! the! chapter,! I! investigated! the! effect! of! expressing!ABAD!and!Aβ!on!lipid!metabolism!in!living!cells,!in!particular!the!effects!of!ABAD!in!the!absence!and!presence!of!elevated! levels!of!Aβ.!To!do!this! I!explored!the! lipid!composition!of!cells!expressing!ABAD!and!Aβ,!using!a!method!called!lipidomics.!
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Figure! 4]18:! Schematic! diagram! of! ESI]MS.% a)! diagram! of! the! entry! of! lipid! extraction!through!a!fine!needle,!large!voltage!applied!to!needle!to!charge!analytes,!b)!simplified!diagram! of! the! steps! involved! in! ESI]MS.! b)! At! quadropole! 1! (Q1)! the! filtration! by!mass! of! parent! ions! occurs,! at! Q2,! collision! of! analytes! occurs! to! produce!product/daughter!ions!and!Q3,!the!filtration!of!the!product!ions!occurs,!and!then!finally!the!detection!of!the!lipids.%
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the! ionisation! chamber! where,! depending! on! the! lipids! being! analysed,! either! a!hydrogen!ion!is!added!or!removed/!left!as!neutral!via!a!high!voltage.!The! lipid! extract! samples! were! analysed! using! Micromass! LCT! mass!spectrometer!with!a!nanoelectrospray!source!(capillary!voltage!of!0.9!kV!and!cone!voltages!of!50!V)!in!order!to!gain!the!lipid!spectra.!Further!analysis,!to!determine!the! product! ion! spectrum! (which! produces! the! different! fragments! of!glycophospholipids! from! the! original! lipid! extract)! was! carried! out! by! a! m/z!fragmentation!scan!following!the!protocol!outlined!in!section!2.5.2.2.!!Once! ESI]MS! was! performed! the! lipid! spectra! were! analysed! to! explore! the!variations!in!the!lipid!content!(figures!4.19!&!4.20).!Initially,!the!positive!ion!mode!shown!in!Figure!4.19!does!not!appear!to!show!major!differences!in!the!PC!species!across!the!conditions!as!the!overall!lipid!levels!are!unchanged.!However,!on!closer!inspection!of!these!positive!ion!mode!results,!where!ABAD!is!expressed!in!HEK!293!cells,! indicated! an! increase! in! sphingomyelin! (SM)! (730.0! m/z).! Notably! NMR!analysis! of!AD!brain! samples! have! reported! a! similar! finding!whereby! SM! levels!were!increased!in!comparison!to!non]demented!age!matched!controls!(Pettegrew!et! al.,! 2001).! An! increase! in! SM! has! also! been! shown! to! increase! rigidity! of! the!cellular!membranes!which!in!turn!promotes!Aβ!production!(Wolozin,!2001).!This!suggests!that!the!increased!expression!of!ABAD!in!AD!could!indirectly!stimulate!Aβ!production! possibly! through! changes! in! lipid! metabolism.! Examination! of! the!negative!ion!spectra!revealed!an!overall!suppression!of!the!lipid!species!PI,!PG!and!PC!when!mAPP!was!present!in!the!HEK!293!cells;!the!dominant!lipid!species!was!phosphatidylethanolamine! (PE)! (744.8! m/z).! The! decrease! of! PI,! PG! and! PC!suggests!a!reduction!in!their!synthesis!or!even!an!increase!in!metabolism!of!these!particular! lipids.! In! order! to! synthesise! these! particular! phospholipids,! cytidine!diphosphate]diacylglycerol!(CDP]DAG)!is!required,!consequently!the!results!imply!that!this!lipid!could!also!be!suppressed!causing!a!reduction!in!the!production!of!PI,!PG!and!PC.!As!the!brain!ages,!neurons!have!been!reported!to!show!reduced!content!of! the! inner! mitochondrial! membrane! lipid,! cardiolipin,! which! is! particularly!important! in! the! regulation! of! mitochondria! membranes! (Ruggiero! et! al.,! 1992,!Chicco!and!Sparagna,!2007).!!
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Figure	   4-­‐19:	   ESI-­‐MS	   analysis	   of	   lipid	   content	   in	   HEK293	   cells	   in	   positive	   ion	  mode.	  Analyses	  of	   positively	   charged	   lipids	   (e.g	  PC	  &	  SM)	  determined	   from	   lipid	  extracts	   from	   HEK293	   cells	   transfected	   with	   DNA	   plasmids	   expressing;	   pcDNA3	  (Control),	   mAPP,	   MTS-­‐ABAD	   or	   mAPP	   with	   MTS-­‐ABAD.	   Labelled	   are	   the	   key	  changes	   seen;	   SM	   –	   sphingomyelin	   and	   PC-­‐phosphatidylcholine.	   The	   main	  changes	   observed	   are	   shown	   in	   the	   spectra	   of	   lipids	   extracted	   from	   ABAD	  expressinh	  HEK	  293	  cells	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	  4-­‐19:	  ESI-­‐MS	  analysis	  of	   lipid	   content	   in	  HEK293	  cells	   in	  positive	   ion	  mode.	  Analyses	   of	   positively	   charged	   lipids	   (e.g	   PC	  &	   SM)	   determined	   from	   lipid	   extracts	  from	   HEK293	   cells	   transfected	   with	   DNA	   plasmids	   expressing;	   pcDNA3	   (Control),	  mAPP,	  MTS-­‐ABAD	  or	  mAPP	  with	  MTS-­‐ABAD.	  Labelled	  are	   the	  key	  changes	  seen;	  SM	  –	   sphingomyelin	   and	   PC-­‐phosphatidylcholine.	   The	  main	   changes	   were	   observed	   in	  the	  spectra	  from	  the	  lipids	  extracted	  from	  HEK	  293	  cells	  expressing	  ABAD	  and	  both	  mAPP	   and	  ABAD.	   In	   the	   presence	   of	   ABAD	   there	   is	   an	   increase	   in	   SM	   and	   in	  mAPP	  and	  ABAD	  there	  is	  an	  increase	  PC.	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Figure	   4-­‐20:	   ESI-­‐MS	   spectra	   of	   lipid	   content	   in	   HEK	   293	   cells	   negavtive	   ion	  spectra,	   analyses	   of	   negatively	   charged	   glycophospholipids	   (e.g	   PS	   &	   PI)	  determined	   from	   lipid	   extracts	   from	   HEK	   293	   cells	   transfected	   with	   DNA	  plasmids	  expressing;	  pcDNA3	  (Control),	  mAPP,	  MTS-­‐ABAD	  or	  mAPP	  with	  MTS-­‐ABAD.	  Labelled	  are	   the	  key	  changes	  seen,	  such	  as	  a	  shift	   to	  PE	  and	  PS	  species	  when	  ABAD	  is	  expressed.	  	  	  	  	  















































ABAD!INTERACTION!WITH!CypD!From!previous!unpublished! research,! an! interaction!between!ABAD!and!CypD!had!been!noted!and!hypothesised!to!be!a!protective!mechanism!where!CypD!was!sequestered!by!ABAD!within!the!mitochondrial!matrix!(Yan!and!Stern,!2005).!This!sequestering! of! CypD! by! ABAD! was! suggested! to! prevent! the! reported!translocation!of!CypD!to!the!IMM,!where!CypD!has!been!observed!to!be!part!of!the!mPTP!(Connern!and!Halestrap,!1992,!Connern!and!Halestrap,!1994,!Yan!and!Stern,!2005).! The!mPTP!has! been! reported! to! open!under! conditions! of! cellular! stress,!resulting! in! necrosis! and! cell! death;! therefore,! indicating! that! this! interaction!between!ABAD!and!CypD,!could!be!a!potential! controlling!mechanism!to!prevent!cell!death!(Li!et!al.,!2004b).!Consequently,!any!disruption!of!this!interaction!could!promote!cell!death,!and!so!as!Aβ!binds!to!both!ABAD!and!CypD,!it!could!change!the!conformation! of! both! ABAD! and! CypD! resulting! in! the! disruption! of! their!interaction.!This!would!mean!that!the!binding!of!Aβ!to!both!ABAD!and!CypD!could!have!multiple!effects!with!ABAD’s!activity!being!distorted!(potentially!changing!the!substrates!it!can!now!use:!see!below)!resulting!in!the!production!of!toxic!products,!whilst!CypD!translocates!to!the!IMM!opening!the!mPTP!(Lustbader!et!al.,!2004,!Du!et!al.,!2008).!!To!investigate!this!potential!interaction,!I!performed!both!immunoprecipitation!and!live!cell!FRET!experiments.!The!immunoprecipitation!studies!did!not!show!any!interaction! between! ABAD! and! CypD;! however,! as! this! interaction! could! be!transient! (see! below)! further! studies! could! be! performed! to! specifically! look! for!such!weak! interactions.!This!would! involve! the!addition!of! cross]linkers! to! these!immunoprecipitation! studies! in! order! to! retain! the!weaker! binding! between! the!proteins! (Kluger! and! Alagic,! 2004).! Interestingly,! previous! experiments! in! the!laboratory! had! indicated! that! it! was! possible! to! achieve! FRET! signals! between!fluorescently! labelled! ABAD! and! CypD! from! fixed! cell! samples! (Ren,! 2008),! and!indeed!I!did!find!an!interaction!occurring!between!ABAD!and!CypD!when!live!cell!FRET! analysis!was! carried! out.! Specifically! a! small! Ratio! A! value!was! calculated!
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which!corresponds!to!a!low!FRET!efficiency!of!~10%!of!the!positive!control!(which!is! set! to! 100%).! This! implies! that! despite! the! immunoprecipitation! experiments,!there! is! a! potential! interaction! between! ABAD! and! CypD.! This! suggests! that! the!original!hypothesis!of!Yan!and!Stern!(2005)!concerning!the!sequestration!of!CypD!by! ABAD! is! not! completely! correct,! as! their! prediction! was! of! a! strong! binding!between! CypD! to! ABAD.! As! such! the! observed!weak/transient! interaction! could!explain!why!nothing!was!seen!with!the!immunoprecipitation!studies!and!hence,!as!indicated!above!it!would!not!be!easily!observed!without!the!use!of!chemical!cross]linkers! to!sustain! the! interaction.!As!well!as! these!modified! immunoprecipitation!studies!further!investigations!into!the!ABAD]CypD!interaction!using!live!cell!FRET!analysis! could! also! include! an! exploration! into! the! conditions!which! control! this!interaction.!Indeed!as!these!FRET!experiments!were!performed!on!live!cells,!it!will!be! possible! to! perform! experiments! with! the! addition! of! Aβ! or! other! oxidative!stresses! and!measure! the! subsequent! FRET! efficiency.! Additionally,! it! would! be!interesting! to! investigate! whether! this! interaction! can! be! seen! using! other!biophysical! methods! such! as! thermal! shift! analysis! and/or! surface! plasmon!resonance!or!isothermal!calorimetry!using!purified!proteins.!!!
ABAD!ACTIVITY!AND!REDUCED!GLUCOSE!! It! has! already! been! established! in! AD,! that! there! are! problems! with! glucose!utilisation,!consequently!this!causes!a!starvation!of!energy!for!neurons!and!so!they!must!resort! to!utilising!alternative!energy!sources.!When!glucose! is!not!available!neurons!use!ketone!bodies!to!produce!energy!from!the!metabolism!of!fatty!acids,!importantly! this! metabolism! uses! ABAD.! Starvation! conditions! increase! the!requirement!for!ketones!as!an!energy!source,!which!may!provide!a!reason!for!the!reported!high!levels!of!ABAD!in!AD!but!also!under!conditions!of!ischaemia!(Yan!et!al.,!1999,!Yan!et!al.,!2000).!!! I!investigated!the!effects!of!reducing!glucose!levels!in!the!medium!surrounding!cells! and! exploring! its! effect! directly! on! the! activity! of! ABAD.! It! is! interesting! to!note! that! Cunnane! et! al.! (2011)! reported! that!within! the!brain,! levels! of! ketone]metabolising!enzymes!are!not!altered!by!changes!in!glucose,!and!I!too!have!shown!
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this! is! also! true! when! investigating! the! protein! expression! of! ABAD,! as! under!decreased!levels!of!glucose!I!did!not!see!any!changes!of!proteins!expression!(figure!4.5).!However,!this!suggests!that!any!changes!in!expression!of!ketone]metabolising!enzymes! such! as! ABAD! is! a! consequence! of! another! factor.! In! this! case! the!instigating! factor(s)! could! be! changes! in! the! available! substrates! or! even! the!presence! of! Aβ! modulating! substrate! specificity.! Yan! et! al.! (1999)! previously!proposed! that! Aβ! induces! cytotoxicity! through! ABAD! by! modifying! ABAD’s!substrate! specificity! to! using! linear! alcohols! and! that! this! reaction! consequently!causes! an! accumulation! of! toxic! aldehydes! (e.g.! 4]HNE! and! MDA)! .! My! results!indicate!that!the!suggestion!that!Aβ!can!alter!the!substrates!that!ABAD!can!use,!this!could!be!investigated!using!the!(])]CHANA!assay!by!repeating!the!reduced!glucose!assays!but!now!in!the!presence!of!Aβ.!Previous!work!has!shown!that!the!addition!of!Aβ! to! cells! expressing!ABAD!has! an! overall! inhibitory! effect! on!ABAD!activity!(Muirhead!et!al.,!2010a),!but!the!question!remains!does!it!change!ABAD’s!substrate!specificity?!The!substrate!preference!of!ABAD!could!be!explored!under!conditions!either!where!Aβ!is!increased!or!glucose!levels!are!depleted!by!the!addition!of!other!known!substrates!of!ABAD!to!the!CHANA!assay!and!observing!the!changes!in!the!fluorescence!emitted!i.e.!if!a!substrate!is!still!utilised!then!it!will!replace!the!CHANA!substrate!with!a!subsequent!reduction!in!fluorescence.!!! In! the! absence! of! Aβ,! I! have!managed! to! show! that! decreased! glucose!within!HEK!293!and!SK]N]SH!cells!causes!an!increase!in!the!activity!of!the!enzyme!ABAD.!This!agrees! !with!the!findings!from!Yan!et!al.!(2000),!where!wild!type!mice!were!reported!to!up]regulate!ABAD!protein!levels!under!cellular!stress!(ischemia)!with!subsequent! reduction! in! the! levels! of! the! ABAD! substrate,! β]hydroxybutyrate.!However,! I!have! found!that! the!actual!activity!of!ABAD!is!enhanced!when!energy!sources!are!depleted!whereas!it!was!previously!only!inferred!as!the!protein!levels!are!increased.!Future!work!will!look!further!into!the!mechanisms!of!regulation!of!this! ABAD! activity! but! at! the! post]translational! modification! level.! At! present!nothing! is! known!about! this!with! regard! to!ABAD!activity,! but! it! is! possible! that!that! the! drop! in! glucose! levels! leads! to,! for! example,! changes! in! the!phosphorylation! state! of! this! protein! which! are! commonly! used! to! modify!
Chapter(5:(Conclusion(and(future(studies(!
124!!
metabolic! enzyme! activity.! As! such! my! experience! in! mass! spectrometry! (see!below)!could!be!utilised!to!look!into!this.!! !The! finding! that! ketonegenesis! in! AD! patients! aids! the! survival! of! neurons!through!increasing!energy!production!when!neurons!are!lacking!glucose,!signifies!that!the!addition!of!a!more!specific!energy!substrate!would!increase!these!benefits!further.! Also! with! the! knowledge! that! the! introduction! of! higher! levels! of! fatty!acids! into! the! diet! of! AD! patients! results! in! these! patients! displaying! cognitive!improvement,!perhaps!suggests!that!the!inhibition!of!ABAD!by!Aβ!is!not!an!on/off!encounter!but!a!graded!response!(Lustbader!et!al.,!2004,!Freemantle!et!al.,!2006,!Lim! et! al.,! 2005,! Henderson,! 2008).! By! determining! the! preferred! substrates! for!ABAD!in!the!presence!of!Aβ!then!this!knowledge!could!be!translated!and!used!as!therapeutic!treatments!for!increasing!energy!production!in!neurons.!!
ABAD!ACTIVITY!IN!THE!PRESENCE!OF!CypD!!! Following! the! findings! that! ABAD! activity! increases! under! reduced! glucose!conditions! in!chapter!4,!and! that! the!FRET!studies! in!chapter!3! indicated!a!close!association! of! ABAD! and! CypD,! an! investigation! was! conducted! to! see! whether!CypD! plays! a! functional! role! through! its! potential! interaction! with! ABAD! by!altering! its! metabolic! activity.! Under! normal! glucose! conditions,! an! increase! in!CypD! expression! was! observed! to! suppress! significantly! the! activity! of! ABAD,!whilst! not! affecting! the! general! mitochondrial! activity.! This! suggests! that! the!interaction!between!CypD!and!ABAD!could!also!be!used!to!regulate!the!enzymatic!function!of!ABAD.!Therefore!this! interaction!of!ABAD!and!CypD!may!be!a!control!point! not! just! for! CypD! translocation! to! the! mPTP! but! it! also! controls! ABAD!activity.!Again!it!is!unknown!at!present,!whether!this!inhibition!of!ABAD!activity!is!a! general! inhibition! of! its! activity! or! whether! it! can! also! change! the! preferred!substrates!that!ABAD!can!utilise.!This!warrants!further!exploration!into!the!action!of! CypD! on! ABAD! activity! under! AD! like! conditions.! These! would! involve! the!investigation! of! ABAD! activity! in! the! presence! of! Aβ! and! CypD! but! also! under!reduced! glucose! concentrations! allowing! for! examination! of! ABAD! activity.! In!particular,! it!would! be! interesting! to! observe! if! ABAD! activity! is! increased! upon!
Chapter(5:(Conclusion(and(future(studies(!
125!!
removal! of! CypD! activity.! Cyclosporine! A! is! an! inhibitor! of! CypD! and! has! been!shown! to! protect! against! some! of! the! toxicities! induced! by!Aβ! (Du! et! al.,! 2008);!however!it!is!not!suitable!as!a!drug!as!it!has!immunosuppressive!side]effects!and!is!also!not!specific!to!CypD.!Therefore!a!more!specific! inhibitor!such!as!antamanide!could!be!used!(Azzolin!et!al.,!2011).!!
ABAD!ACTIVITY!AND!LIPID!COMPOSITION!The!effect!of!ABAD!on! lipid!metabolism!was!also! investigated!to!explore! if! the!presence!of!Aβ!and!ABAD!altered!the!lipid!composition!of!cells.!It!was!found!that!Aβ! and! ABAD,!when! their! levels! of! expression!were! increased! in! HEK! 293! cells!either!singularly!or!together,!did!indeed!affect!the!composition!of!lipids.!!Lipids!are!crucial! for! membrane! structure! and! signalling.! Their! composition! within!membranes! has! been! reported! to! influence! Aβ! production,! for! example! the!presence!of!cholesterol!in!membranes!increases!the!rigidity!of!the!membrane!and!as!such!induces!the!amyloidogenic!cleavage!of!APP!(Wolozin,!2001).!!The!change!in!cellular!lipid!composition!when!ABAD!was!expressed!in!HEK!293!cells!revealed!an!increase!in!SM!species,!which!affects!rigidity!of!lipid!membranes,!and! a! shift! in! PE! and! PS! lipid! species,!which! implies! a! breakdown! in! large! fatty!acids.!In!particular!the!reduction!of!larger!lipids!from!the!lipid!profile!and!the!shift!to! PE! and!PS! species!when!ABAD! is! expressed! alone! implies! that! the! long! chain!polyunsaturated! fatty! acids! are! being! metabolised! to! generate! an! alternative!energy!source,!other! than!glycolysis.!ABAD!expression!consequently! increases!β]oxidation!and!additionally,!when!Aβ!and!ABAD!were!expressed!together,!there!was!an!overall!suppression!of!larger!lipid!species.!This!further!signifies!a!catabolism!of!fatty!acids!by!β]oxidation! in! the!presence!of!ABAD.!Therefore,! I!have!shown!that!expression! of! ABAD! in! HEK! 293! cells! does! influence! specific! changes! in! lipid!metabolism.! This! preliminary! work! opens! up! the! possibility! for! a! further! more!detailed! investigation! into! the! lipid! and! fatty! acid! composition! when! ABAD! is!expressed! but! also! when! Aβ! is! present! and! when! glucose! levels! are! reduced.!!!Additionally,!analysis!should!include!exploration!of!the!lipid!composition!and!fatty!acid! content! from! brain! material! using! transgenic! animals! that! have! previously!
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HEK! cells! expressing! MTSBCypDBECFP,! emission! spectra! when! excited! donor!fluorophore!ECFP!at!436nm.!!Values!for!(A)!the!ratio!A!!equation.!
BB1 
!HEK! cells! expressing! MTSBABADBEYFP,! emission! spectra! when! acceptor!fluorophore,!EYFP,!is!excitted!at!517nm.!Values!for!(E)!the!ratio!A!equation.!
BB2 
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Abstract
It is well established that the intracellular accumulation of Aβ (amyloid β-peptide) is associated with AD
(Alzheimer’s disease) and that this accumulation is toxic to neurons. The precise mechanism by which this
toxicity occurs is not well understood; however, identifying the causes of this toxicity is an essential step
towards developing treatments for AD. One intracellular location where the accumulation of Aβ can have a
major effect is within mitochondria, where mitochondrial proteins have been identiﬁed that act as binding
sites for Aβ, and when binding occurs, a toxic response results. At one of these identiﬁed sites, an enzyme
known as ABAD (amyloid-binding alcohol dehydrogenase), we have identiﬁed changes in gene expression
in the brain cortex, following Aβ accumulation within mitochondria. Speciﬁcally, we have identiﬁed two
proteins that are up-regulated not only in the brains of transgenic animal models of AD but also in those of
human sufferers. The increased expression of these proteins demonstrates the complex and counteracting
pathways that are activated in AD. Previous studies have identiﬁed approximate contact sites between
ABAD and Aβ; on basis of these observations, we have shown that by using a modiﬁed peptide approach
it is possible to reverse the expression of these two proteins in living transgenic animals and also to
recover mitochondrial and behavioural deﬁcits. This indicates that the ABAD–Aβ interaction is potentially an
interesting target for therapeutic intervention. To explore this further we used a ﬂuorescing substrate mimic
to measure the activity of ABAD within living cells, and in addition we have identiﬁed chemical fragments
that bind to ABAD, using a thermal shift assay.
Introduction
A link between mitochondrial dysfunction and neurode-
generative conditions, such as AD (Alzheimer’s disease),
has long been suggested to exist. Observations of altered
cerebral blood flow and bioenergetic deficits in dementia
patients, made using positron electron tomography [1,2],
initiated research into the function of mitochondria in
neurodegeneration as they are central to cellular energy
metabolism. Evidence of the pivotal role of metabolic
pathways and free-radical turnover in mitochondria in
normal aging and neurodegenerative diseases has since
accumulated [3,4]. For example, Parker et al. detected reduced
cytochrome c oxidase activity in platelets [5] and the brains
of AD patients [6], whereas Sayre et al. found increased
levels of 4-HNE (4-hydroxynonenal), a product of lipid
peroxidation, in AD brain tissue in comparison with controls
[7]. Due to the proximity of mitochondrial DNA to ROS
Key words: Alzheimer’s disease (AD), amyloid-binding alcohol dehydrogenase (ABAD),
cyclohexenyl amine naphthalene alcohol (CHANA), cyclophilin D (CypD), intracellular amyloid
β-peptide (intracellular Aβ), mitochondrial dysfunction.
Abbreviations used: Aβ, amyloid β-peptide; ABAD, amyloid-binding alcohol dehydrogenase;
AD, Alzheimer’s disease; Cdk5, cyclin-dependent kinase 5; CHANA, cyclohexenyl amine
naphthalene alcohol; CHANK, cyclohexenyl amine naphthalene ketone; CypD, cyclophilin D; DP,
decoy peptide; EFHD 2, EF-hand domain containing protein 2; Ep-1, endophilin-1; ER, endoplasmic
reticulum; JNK, c-Jun-N-terminal kinase; mAPP, mutant amyloid precursor protein; ROS, reactive
oxygen species; SPR, surface plasmon resonance; mPTP, mitochondrial permeability transition
pore; Tg-mAPP, mAPP-overexpressing transgenic; TOM, translocase of outer mitochondrial
membrane; TRX, thioredoxin 1.
1To whom correspondence should be addressed (email fjg1@st-andrews.ac.uk).
(reactive oxygen species), which are naturally produced
in the electron transport chain, this DNA is thought to
accumulate mutations over time, which can lead to increasing
mitochondrial dysfunction and increased production of ROS
with age [8–10]. Keymitochondrial enzymes that are affected
by AD include cytochrome c oxidase [5,11], the pyruvate
dehydrogenase complex, α-ketoglutarate dehydrogenase and
isocitrate dehydrogenase [12,13].
Lustbader et al. [14] used immunoelectron microscopy
to show that mitochondrial Aβ (amyloid β-peptide) (both
the 1–40 and 1–42 forms) localizes inside the mitochondria
of Tg-mAPP [mAPP (mutant amyloid precursor protein)-
overexpressing transgenic] animals and, significantly, the
human AD brain. A further study showed that Aβ
accumulation in the mitochondria from Tg-mAPP mice and
the cerebral cortex of humanADbrains is significantly higher
than that in non-transgenic mice and non-AD brains [15].
More recent studies indicate that mitochondrial dysfunction
and the accumulation of mitochondrial Aβ [and ABAD
(amyloid-binding alcohol dehydrogenase): see below] can
be observed in the early stages of AD in other commonly
used transgenic animal strains, including the popular triple
transgenic mouse model (human APPSWE, TauP301L and
PS1M146V [16]).
The origin of this mitochondrial Aβ is still under
debate and there is experimental evidence of the local
production (e.g. the presence of the γ -secretase complex
within mitochondria) and/or the import of Aβ from the
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cytosol via the TOM (translocase of outer mitochondrial
membrane) [17–19]. In addition to the ongoing efforts to
determine how Aβ occurs within mitochondria, the other
key question regards the action of Aβ once it is located
within mitochondria. The addition of Aβ to cell cultures
induces the dysfunction of mitochondrial respiration, ATP
depletion and production of ROS [20,21]; the exposure of
isolated mitochondria to Aβ reduces complex IV activity
[22] and induces the formation of the permeability transition
pore, which is linked to cell death [23]. In addition to
these organelle-level changes, in the last decade attention has
been increasingly focused on two mitochondrial proteins,
ABAD (amyloid binding alcohol dehydrogenase) and CypD
(cyclophilin D), both of which appear able to mediate the
toxicity of the Aβ peptide. The binding of both proteins to
Aβ (both the 1–40 and 1–42 forms) has been demonstrated at
nanomolar Aβ concentrations, and Aβ accumulation within
cells is known to result in an increase in the expression of
both these proteins [23–25].
CypD
CypD, a peptidylprolyl isomerase F, is found in the
mitochondrial matrix and it translocates to the inner
mitochondrial membrane during times of oxidative stress
where it is thought to play a role in the opening of the mPTP
(mitochondrial permeability transition pore) [26]. CypD is
considered to be a part of themPTP as it associates withANT
(adenine nucleotide translocase) and possibly other factors,
such as theVDAC (voltage-dependent anion channel) and the
PiC (mitochondrial phosphate carrier), to contribute to
the opening of the pore [27]. Using a variety of methods such
as immunoprecipitation, co-localization and SPR (surface
plasmon resonance) assays it was shown that CypD can
bind to Aβ at nanomolar concentrations of Aβ. However,
no direct contact sites have yet been identified [23]. Du et al.
[23] also reported that under Aβ-rich conditions in the aging
brain, CypD expression levels are increased and coincide
with increased levels of ROS production. Further studies
using Tg-mAPP mice deficient in the gene encoding CypD,
revealed that the interaction of CypD with Aβ can result
in cellular stress and cell death [23,25]. Notably, neurons
derived from CypD-deficient animals are resistant to Aβ-
induced opening of the mPTP and are thus protected against
Aβ- and oxidative stress-induced cell death. These animals
also exhibited significantly improved learning and memory
functions in comparison with transgenic mAPP mice with
normal expression of CypD [25].
ABAD
ABAD is the most characterized intracellular Aβ-binding
protein and it was first identified in 1997 using a yeast
two-hybrid screen [24]. It was originally identified within
the ER (endoplasmic reticulum) and was termed ERAB
(ER-associated amyloid-binding protein) [24]; however, later
studies confirmed its presence inside mitochondria [28]. The
action of this enzyme is primarily to catalyse the reduction
of aldehydes and ketones or the reverse reaction of oxidation
from alcohols for energy production. As described in more
detail by Muirhead et al. [29] ABAD acts on a range of
substrates, indicating the variety of functions it can have
within the cell. This variety of potential substrates correlates
with the finding that ABAD appears to act as a molecular
switch. In the presence of low levels of Aβ, ABAD can
exhibit neuroprotective effects, and its increased expression
is protective in animal models of Parkinsonism [30] and
metabolic stress [31]; however, as Aβ levels rise, it appears
that ABAD loses its ability to protect and that it enhances
Aβ toxicity [32]. X-ray crystallography studies of human
and rat ABAD have provided a clear representation of the
catalytic core of ABAD and enabled the identification of
key residues involved in substrate binding and interaction
with Aβ [33]. However, the precise identity of the residues
involved in theAβ–ABAD interaction could not be identified
by means of crystallography, since loop D, the region that
is thought to bind Aβ, was disordered in the structure
[14]. Interaction with Aβ not only inhibits ABAD’s enzyme
function (though notably only atmicromolar concentrations)
[28,34], but also causes severe mitochondrial dysfunction
and cellular toxicity [14,32], which cannot be attributed to
a loss of enzyme function alone. Proteomics studies on mice
overexpressing ABAD and mAPP revealed that in the living
brain theABAD–Aβ interaction also affects the expression of
proteins. Proteins that were specifically identified were Ep-1
(endophilin-1) [35] and Prdx-2 (peroxiredoxin-2) [36], both
of which were found to be more abundant in human AD
brains in comparison with controls [35,36]. To date, the link
between these two proteins and mitochondrial dysfunction
remains unclear. However, evidence exists that increased
levels of Ep-1 can cause the activation of JNK (c-Jun-N-
terminal kinase) [35,37]. JNK is a stress kinase that has
been linked to Aβ production in neuronal cells [38,39],
whose action is associated with the early stages of AD [40].
Conversely, Prdx-2 is an antioxidant protein and an increase
in its expression can protect against Aβ-induced toxicity [36].
Thus the increased expression of these two proteins typifies
competing pathways that are activated in an AD afflicted
brain.
Another important metabolic function located in mi-
tochondria is Ca2+ homoeostasis. Evidence of disturbed
Ca2+ homoeostasis [41] and alterations in Ca2+ regulated
proteins, especially the neuronal proteinase calpain and its
targets, has been detected in human AD brains, in human
cortical neuron cultures in vitro [42,43] and in transgenic
mice [44]. Interestingly, a link between the calpain-regulated
Cdk5 (cyclin-dependent kinase 5) and Prdx-2 inactivation
by phosphorylation has been discovered in a model of
Parkinson’s disease [45]. In addition, Cdk5 had been earlier
identified as a candidate kinase for the mediation of neuronal
toxicity in AD [46–48]. The relevance of this pathway
to Prdx-2 function in AD has not been investigated so
far. Our own studies indicate that the phosphorylation of
Thr89 in Prdx-2 can regulate the observed protection against
Aβ-induced toxicity (E. Borger, unpublished work). More
C©The Authors Journal compilation C©2011 Biochemical Society
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recently a novel Ca2+ -binding protein, EFHD 2 (EF-hand
domain containing protein 2; swiprosin 1) was also linked
to one of the hallmarks of AD [49]. EFHD 2 is associated
with hyperphosphorylated tau protein in a mouse tauopathy
model and in human AD brains to a greater degree than it
is in control tissues [49]. Additionally, it was reported that
protein levels of EFHD 2 were found to have increased in
AD cases in comparison with those in controls [49], and our
own studies suggest that this is also the case in the Tg-mAPP
mouse model, which does not develop tauopathy (E. Borger,
unpublishedwork). The functionofEFHD2 inneuronal cells
is still unknown, but its associationwith twoofADhallmarks
points towards its potential importance in AD pathology.
Taken together, research on human dementia patients
and studies using animal as well as in vitro models for
AD have shown that all key functions of mitochondria are
affected in AD. A detrimental link between impaired brain
energy metabolism, ROS production and disturbed Ca2+
homoeostasis has also been established in the case of other
neuropathological conditions such as delirium, ischaemia and
hypoglycaemia. Consequently, Blass [50,51] and Lin and Beal
[52] have proposed the role of a downward ‘mitochondrial
spiral’ in the development of neurodegenerative diseases, in
particularly with regard to AD.
Therapeutic targets and development of
assays
The proposed binding site of Aβ on ABAD, ‘loop D’,
was identified through a range of complimentary techniques
including X-ray crystallography and mutagenesis studies
[14]. It has been shown that a synthetic peptide consisting of
residues 92–120, which forms this loop, can be used as a DP
(decoy peptide), which competes with ABAD as a partner
that binds to Aβ. Using SPR, it was shown that this DP
was able to prevent the binding of Aβ to ABAD [14]. The
same region of ABAD, identified independently through an
antisense peptide approach, was found to bind biotinylated
Aβ with aKd (dissociation constant) of 107 nM, using ELISA
[53]. Cellular studies of the DP effects, using a Tat-DP fusion
peptide to allow the peptide to cross the cellmembrane, found
that the application of the peptide protected neurons (from
wild-type, Tg-ABAD and Tg-ABAD/mAPP mice) against
Aβ-induced toxicity [14]. Similarly, the introduction of DP-
TRX (thioredoxin 1; an enzyme introduced here in order
to stabilize the peptide) into cell cultures using a lentiviral
approach, revealed that DP-TRX-transfected cells showed
decreased apoptosis, decreased LDH (lactate dehydrogenase)
release and increased cell viability after treatment with Aβ in
comparison with controls [54]. Compelling evidence of the
effectiveness of the peptide was provided by in vivo studies
in transgenic animals, where a fusion peptide consisting of
amino acids 93–116 of loop D with a Tat sequence and
a mitochondrial-targeting sequence [Tat-mito-DP(93–116)]
was found to alter levels of AD biomarker proteins Prdx-
2 and Ep-1 [35,36]. Intraperitoneal injection of Tat-mito-
DP(93–116) into Tg-mAPP mice resulted in a reduction in
Prdx-2 levels in thesemice to levels thatwere comparablewith
those in non-transgenic mice [36]. Similarly, Ep-1 levels were
elevated in double transgenic ABAD/mAPP mice and
were found to return to basal levels when the mice
were treated with Tat-mito-DP(93–116) [35]. In addition,
behavioural studies revealed that treatment with the DP
improved short-term memory performance in transgenic
AD mouse models. Recently, Yao et al. demonstrated that
double transgenic mAPP/Tat-mito-DP(91–119) mice as well
asmAPPmicewhen systemically treatedwith theDP, showed
significant improvement in the radial-arm water maze test
of short-term memory performance in comparison with
untreated mAPP mice [55].
In order to develop therapeutic compounds that target the
Aβ–ABAD interaction, a robust method for monitoring
the activity of the desired drug target is required. The
use of purified ABAD protein to measure enzyme activity
in vitro is well documented [29]. Utilizing the absorption
of NADH at 340 nm, the rate of reduction in substrate can
be measured by means of spectroscopy. Recently, we and
our collaborators developed a cell-based assay that enables
the study of ABAD activity in intact living cells. The assay
uses a fluorescent ABAD substrate mimic, CHANA (cyclo-
hexenyl amine naphthalene alcohol), which is based on the
endogenous ABAD substrate oestradiol. CHANA is a non-
fluorescent substrate under assay conditions, whereas the
reaction product,CHANK(cyclohexenyl amine naphthalene
ketone) fluoresces in non-aqueous environments, e.g. in
cell membranes [56]. Due to these different photochemical
properties, the selective detection of the accumulation of
CHANK is possible. Thus the conversion of CHANA to
CHANK, and hence ABAD activity, can be monitored by
means of fluorescence microscopy. This novel approach has
recently been improved upon by the means of synthesis
of the individual stereoisomers of CHANA. (− )-CHANA
was found to be selectively metabolized by ABAD, whereas
(+ )-CHANA showed a much higher level of background
oxidation by other cellular dehydrogenases [57]. Thus, using
(− )-CHANA, we have laid the foundations for a cell-
based assay monitoring of ABAD activity. When using
(− )-CHANA, metabolism was seen to be substantially
diminished in cells treated with a known ABAD inhibitor,
AG18051 [33]. Importantly, it was also demonstrated that Aβ
can inhibit ABAD activity in living cells. Upon addition of
22 μM Aβ(1–42), HEK-293 cells (human embryonic kidney
cells) were shown to exhibit a significant decrease in (− )-
CHANAmetabolism of approximately 20%. It is hoped that
further development of this system will provide a robust
cell-based assay for use in the identification of potential
modulators of ABAD function [57].
The future
AD is a complex disease, and likewise it becomes more and
more apparent that the toxicity of the Aβ peptide is also
a complex process. Indeed, although many approaches to
explainADpathology have centred on extracellular Aβ, there
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Figure 1 Consequences of mitochondrial Aβ
APP (amyloid precursor protein) can be transported to mitochondria, where it interacts with TOM and TIM (translocase of the
inner membrane), disturbing mitochondrial protein import (1). Aβ can be imported into mitochondria via TIM and TOM and
is found associated with the inner mitochondrial membrane, disrupting mitochondrial respiration and leading to an excess
production of ROS (2). Aβ has been found to interact with ABAD in the mitochondrial matrix, inhibiting enzyme activity (3).
The Aβ–ABAD interaction also leads to an up-regulation of AD biomarkers Ep-1 (4) and Prdx-2 (5). At the inner mitochondrial
membrane, Aβ can interact with CypD, which is involved in the formation of mPTP and Ca2+ -release from mitochondria
(6). Aβ can be found in the cytosol, disturbing cell signalling, protein degradation and causing ROS production, which leads
to an increase in cytosolic Ca2+ (7). Ca2+ -mediated Cdk5 activation has been found to inhibit Prdx-2’s antioxidant function.
has been lesser focus on the involvement of intracellular
species of Aβ. Our studies with our collaborators have
focused on these events (summarized in Figure 1). They
suggest that the one-drug and one-target approaches for
the treatment of AD are unlikely to constitute an effective
strategy of treatment of AD. Consequently, the treatment of
this disease will probably require a three-pronged approach,
targeting, for example: (i) the formation/clearance of Aβ
and that of hyperphosphorylated tau; (ii) the support and
stabilization of the remaining neuronal networks; and (iii)
protection of potential sensitive intracellular targets. The
integrity and function of mitochondria is one such sensitive
intracellular target, and though ABAD and CypD are not
classical drug targets they are important players in the
sequence of events resulting in mitochondrial dysfunction.
Therefore future approaches for the treatment of AD will
greatly benefit from an understanding of their involvement
in AD.
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